US20200054346A1 - Composite joint arthroplasty systems and methods - Google Patents
Composite joint arthroplasty systems and methods Download PDFInfo
- Publication number
- US20200054346A1 US20200054346A1 US16/660,964 US201916660964A US2020054346A1 US 20200054346 A1 US20200054346 A1 US 20200054346A1 US 201916660964 A US201916660964 A US 201916660964A US 2020054346 A1 US2020054346 A1 US 2020054346A1
- Authority
- US
- United States
- Prior art keywords
- bone
- facing side
- component
- bone anchoring
- articulating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 238000000034 method Methods 0.000 title claims description 84
- 238000011882 arthroplasty Methods 0.000 title description 18
- 239000002131 composite material Substances 0.000 title description 3
- 210000000988 bone and bone Anatomy 0.000 claims abstract description 248
- 238000004873 anchoring Methods 0.000 claims abstract description 204
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims abstract description 44
- 239000010936 titanium Substances 0.000 claims abstract description 42
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 claims abstract description 41
- 229910052719 titanium Inorganic materials 0.000 claims abstract description 41
- 239000002105 nanoparticle Substances 0.000 claims abstract description 35
- 238000002844 melting Methods 0.000 claims abstract description 22
- 230000008018 melting Effects 0.000 claims abstract description 22
- 239000004408 titanium dioxide Substances 0.000 claims abstract description 18
- 238000005266 casting Methods 0.000 claims abstract description 17
- 239000002071 nanotube Substances 0.000 claims abstract description 17
- 239000011148 porous material Substances 0.000 claims abstract description 15
- 239000002344 surface layer Substances 0.000 claims abstract description 14
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 claims abstract description 13
- 239000010941 cobalt Substances 0.000 claims abstract description 13
- 229910017052 cobalt Inorganic materials 0.000 claims abstract description 13
- 239000011651 chromium Substances 0.000 claims abstract description 12
- 229910052804 chromium Inorganic materials 0.000 claims abstract description 12
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 28
- 229910052751 metal Inorganic materials 0.000 claims description 27
- 239000002184 metal Substances 0.000 claims description 27
- 238000010438 heat treatment Methods 0.000 claims description 22
- 230000008569 process Effects 0.000 claims description 20
- 108010010803 Gelatin Proteins 0.000 claims description 14
- 229920000159 gelatin Polymers 0.000 claims description 14
- 239000008273 gelatin Substances 0.000 claims description 14
- 235000019322 gelatine Nutrition 0.000 claims description 14
- 235000011852 gelatine desserts Nutrition 0.000 claims description 14
- 235000011187 glycerol Nutrition 0.000 claims description 14
- 238000004519 manufacturing process Methods 0.000 claims description 11
- 239000010952 cobalt-chrome Substances 0.000 claims description 10
- 229910000531 Co alloy Inorganic materials 0.000 claims description 9
- WAIPAZQMEIHHTJ-UHFFFAOYSA-N [Cr].[Co] Chemical compound [Cr].[Co] WAIPAZQMEIHHTJ-UHFFFAOYSA-N 0.000 claims description 9
- 150000002739 metals Chemical class 0.000 claims description 8
- 230000000295 complement effect Effects 0.000 claims description 7
- 238000010146 3D printing Methods 0.000 claims description 6
- 238000007743 anodising Methods 0.000 claims description 5
- 238000000149 argon plasma sintering Methods 0.000 claims description 4
- 238000003825 pressing Methods 0.000 claims description 4
- 230000008859 change Effects 0.000 claims description 3
- 238000003466 welding Methods 0.000 claims description 3
- 238000002048 anodisation reaction Methods 0.000 claims description 2
- 239000000470 constituent Substances 0.000 abstract description 2
- 239000007943 implant Substances 0.000 description 16
- 210000003127 knee Anatomy 0.000 description 11
- 239000000463 material Substances 0.000 description 9
- 239000000843 powder Substances 0.000 description 9
- 239000011230 binding agent Substances 0.000 description 8
- 239000000203 mixture Substances 0.000 description 7
- 230000002093 peripheral effect Effects 0.000 description 6
- 230000009471 action Effects 0.000 description 5
- 230000015572 biosynthetic process Effects 0.000 description 5
- 230000008901 benefit Effects 0.000 description 4
- 210000002303 tibia Anatomy 0.000 description 4
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- MTHLBYMFGWSRME-UHFFFAOYSA-N [Cr].[Co].[Mo] Chemical compound [Cr].[Co].[Mo] MTHLBYMFGWSRME-UHFFFAOYSA-N 0.000 description 3
- 238000004891 communication Methods 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 238000002513 implantation Methods 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 210000000689 upper leg Anatomy 0.000 description 3
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- 229910000684 Cobalt-chrome Inorganic materials 0.000 description 2
- -1 Titanium halide Chemical class 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 230000006835 compression Effects 0.000 description 2
- 238000007906 compression Methods 0.000 description 2
- 238000009792 diffusion process Methods 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000000629 knee joint Anatomy 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- HLXZNVUGXRDIFK-UHFFFAOYSA-N nickel titanium Chemical compound [Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ti].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni].[Ni] HLXZNVUGXRDIFK-UHFFFAOYSA-N 0.000 description 2
- 229910001000 nickel titanium Inorganic materials 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 2
- 239000000376 reactant Substances 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 229910045601 alloy Inorganic materials 0.000 description 1
- 239000000956 alloy Substances 0.000 description 1
- 239000000010 aprotic solvent Substances 0.000 description 1
- 238000000498 ball milling Methods 0.000 description 1
- 239000002639 bone cement Substances 0.000 description 1
- 239000012159 carrier gas Substances 0.000 description 1
- SFJBWZNTPHYOEH-UHFFFAOYSA-N cobalt Chemical compound [Co].[Co].[Co] SFJBWZNTPHYOEH-UHFFFAOYSA-N 0.000 description 1
- 238000005056 compaction Methods 0.000 description 1
- 230000001054 cortical effect Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000003792 electrolyte Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 239000010419 fine particle Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000010410 layer Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 239000002086 nanomaterial Substances 0.000 description 1
- 230000021368 organ growth Effects 0.000 description 1
- 230000000399 orthopedic effect Effects 0.000 description 1
- 238000007614 solvation Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 229910021324 titanium aluminide Inorganic materials 0.000 description 1
- XJDNKRIXUMDJCW-UHFFFAOYSA-J titanium tetrachloride Chemical compound Cl[Ti](Cl)(Cl)Cl XJDNKRIXUMDJCW-UHFFFAOYSA-J 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/14—Surgical saws
- A61B17/15—Guides therefor
- A61B17/154—Guides therefor for preparing bone for knee prosthesis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/14—Surgical saws
- A61B17/142—Surgical saws with reciprocating saw blades, e.g. with cutting edges at the distal end of the saw blades
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/14—Surgical saws
- A61B17/15—Guides therefor
- A61B17/154—Guides therefor for preparing bone for knee prosthesis
- A61B17/155—Cutting femur
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/14—Surgical saws
- A61B17/15—Guides therefor
- A61B17/154—Guides therefor for preparing bone for knee prosthesis
- A61B17/157—Cutting tibia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/16—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans
- A61B17/1662—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans for particular parts of the body
- A61B17/1675—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans for particular parts of the body for the knee
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/16—Instruments for performing osteoclasis; Drills or chisels for bones; Trepans
- A61B17/17—Guides or aligning means for drills, mills, pins or wires
- A61B17/1739—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body
- A61B17/1764—Guides or aligning means for drills, mills, pins or wires specially adapted for particular parts of the body for the knee
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/3859—Femoral components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/38—Joints for elbows or knees
- A61F2/389—Tibial components
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/46—Special tools for implanting artificial joints
- A61F2/4603—Special tools for implanting artificial joints for insertion or extraction of endoprosthetic joints or of accessories thereof
- A61F2/461—Special tools for implanting artificial joints for insertion or extraction of endoprosthetic joints or of accessories thereof of knees
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F10/00—Additive manufacturing of workpieces or articles from metallic powder
- B22F10/20—Direct sintering or melting
- B22F10/28—Powder bed fusion, e.g. selective laser melting [SLM] or electron beam melting [EBM]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods
- A61B17/56—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor
- A61B2017/568—Surgical instruments or methods for treatment of bones or joints; Devices specially adapted therefor produced with shape and dimensions specific for an individual patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30721—Accessories
- A61F2/30744—End caps, e.g. for closing an endoprosthetic cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30003—Material related properties of the prosthesis or of a coating on the prosthesis
- A61F2002/30004—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
- A61F2002/30011—Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30331—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30331—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements made by longitudinally pushing a protrusion into a complementarily-shaped recess, e.g. held by friction fit
- A61F2002/30332—Conically- or frustoconically-shaped protrusion and recess
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30448—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30451—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements soldered or brazed or welded
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30329—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2002/30476—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements locked by an additional locking mechanism
- A61F2002/305—Snap connection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2002/30001—Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
- A61F2002/30316—The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30535—Special structural features of bone or joint prostheses not otherwise provided for
- A61F2002/30604—Special structural features of bone or joint prostheses not otherwise provided for modular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30818—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves castellated or crenellated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/3084—Nanostructures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30841—Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30841—Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes
- A61F2002/30845—Sharp anchoring protrusions for impaction into the bone, e.g. sharp pins, spikes with cutting edges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2/30771—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves
- A61F2002/30878—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth applied in original prostheses, e.g. holes or grooves with non-sharp protrusions, for instance contacting the bone for anchoring, e.g. keels, pegs, pins, posts, shanks, stems, struts
- A61F2002/30884—Fins or wings, e.g. longitudinal wings for preventing rotation within the bone cavity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3092—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
- A61F2002/3093—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth for promoting ingrowth of bone tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30968—Sintering
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/3097—Designing or manufacturing processes using laser
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/3094—Designing or manufacturing processes
- A61F2002/30985—Designing or manufacturing processes using three dimensional printing [3DP]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00023—Titanium or titanium-based alloys, e.g. Ti-Ni alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00029—Cobalt-based alloys, e.g. Co-Cr alloys or Vitallium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00011—Metals or alloys
- A61F2310/00035—Other metals or alloys
- A61F2310/00059—Chromium or Cr-based alloys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00005—The prosthesis being constructed from a particular material
- A61F2310/00365—Proteins; Polypeptides; Degradation products thereof
- A61F2310/00383—Gelatin
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F10/00—Additive manufacturing of workpieces or articles from metallic powder
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2207/00—Aspects of the compositions, gradients
- B22F2207/11—Gradients other than composition gradients, e.g. size gradients
- B22F2207/17—Gradients other than composition gradients, e.g. size gradients density or porosity gradients
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2998/00—Supplementary information concerning processes or compositions relating to powder metallurgy
- B22F2998/10—Processes characterised by the sequence of their steps
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F2999/00—Aspects linked to processes or compositions used in powder metallurgy
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F3/00—Manufacture of workpieces or articles from metallic powder characterised by the manner of compacting or sintering; Apparatus specially adapted therefor ; Presses and furnaces
- B22F3/10—Sintering only
- B22F3/11—Making porous workpieces or articles
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F7/00—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression
- B22F7/06—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression of composite workpieces or articles from parts, e.g. to form tipped tools
- B22F7/062—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression of composite workpieces or articles from parts, e.g. to form tipped tools involving the connection or repairing of preformed parts
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B22—CASTING; POWDER METALLURGY
- B22F—WORKING METALLIC POWDER; MANUFACTURE OF ARTICLES FROM METALLIC POWDER; MAKING METALLIC POWDER; APPARATUS OR DEVICES SPECIALLY ADAPTED FOR METALLIC POWDER
- B22F7/00—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression
- B22F7/06—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression of composite workpieces or articles from parts, e.g. to form tipped tools
- B22F7/08—Manufacture of composite layers, workpieces, or articles, comprising metallic powder, by sintering the powder, with or without compacting wherein at least one part is obtained by sintering or compression of composite workpieces or articles from parts, e.g. to form tipped tools with one or more parts not made from powder
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y10/00—Processes of additive manufacturing
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B33—ADDITIVE MANUFACTURING TECHNOLOGY
- B33Y—ADDITIVE MANUFACTURING, i.e. MANUFACTURING OF THREE-DIMENSIONAL [3-D] OBJECTS BY ADDITIVE DEPOSITION, ADDITIVE AGGLOMERATION OR ADDITIVE LAYERING, e.g. BY 3-D PRINTING, STEREOLITHOGRAPHY OR SELECTIVE LASER SINTERING
- B33Y80/00—Products made by additive manufacturing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
- Y02P10/00—Technologies related to metal processing
- Y02P10/25—Process efficiency
Definitions
- the present disclosure relates to surgical systems and methods. More specifically, the present disclosure relates to implants and related methods for joint arthroplasty.
- Joint arthroplasty procedures are surgical procedures in which one or more articulating surfaces of a joint are replaced with prosthetic articulating surfaces. Such procedures are becoming increasingly commonplace, for many joints of the body.
- the various systems and methods of the present disclosure have been developed in response to the present state of the art, and in particular, in response to the problems and needs in the art that have not yet been fully solved by currently available joint arthroplasty systems and methods.
- the systems and methods of the present disclosure may provide joint implants and instruments that provide enhanced bone fixation, less wear debris, and/or streamlined implantation.
- a prosthesis may be designed to replace an articular surface on bone.
- the prosthesis may have an articulating component formed via casting, and a bone anchoring component having a 3D printed structure.
- the articulating component may have an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape.
- the bone anchoring component may have a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side.
- the bone anchoring component joint-facing side may be secured to the articulating component bone-facing side.
- the bone anchoring component bone-facing side may have a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores.
- the bone anchoring component may be formed of DMLS (direct metal laser sintered) Titanium, and the 3D printed structure may have a porous structure.
- the porous structure may have a lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side.
- the bone anchoring component joint-facing side may have a near solid structure with little or no porosity.
- the bone anchoring component bone-facing side may have a surface layer of Titanium Dioxide nanotubes formed via anodization.
- the Titanium Dioxide nanotubes may have an anatase structure.
- the articulating component may be formed of an alloy of Cobalt Chromium.
- the alloy of Cobalt Chromium may have one or more crystalline structures established by a casting process used to form the articulating component.
- the bone anchoring component joint-facing side may be secured to the articulating component bone-facing side via a bonding process occurring at a bonding temperature far below melting temperatures of Cobalt and Chromium, such the crystalline structures are not significantly modified by the bonding process.
- the bonding process may occur at a bonding temperature of about 500° C.
- the prosthesis may further have a bonding zone, between the bone anchoring component joint-facing side and the articulating component bone-facing side, formed of melted and re-solidified Titanium nanoparticles.
- the bone anchoring component joint-facing side may additionally or alternatively be secured to the articulating component bone-facing side via a laser welding process around the perimeter and/or along the seams of the two components. Additionally or alternatively, the two components may also be laser welded along the perimeter and/or seams with the addition of a metallic powder and binder mixture along the weld lines. Specifically, a metal powder and binder mixture may be placed along the weld lines and subsequently melted with a laser. The re-solidified metal may bond the bone anchoring component and the articulating component together.
- the metallic powder and binder mixture may include titanium powder and a binder consisting of gelatin, glycerin and/or PVA.
- the metallic powder may additionally or alternatively include a cobalt and chromium powder and a binder consisting of gelatin, glycerin or PVA.
- a method may be designed for manufacturing a prosthesis for replacing an articular surface on a bone.
- the method may include casting an articulating component with an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape.
- the method may further include 3D printing a bone anchoring component with a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side with a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores.
- the method may further include securing the bone anchoring component joint-facing side to the articulating component bone-facing side.
- 3D printing the bone anchoring component may include direct metal laser sintering Titanium to form a porous structure.
- Forming the porous structure may include providing lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side.
- the method may further include anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side.
- the method may further include heating the bone anchoring component to a temperature sufficient to change at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
- Casting the articulating component may include casting the articulating component from an alloy of Cobalt Chromium. Casting the articulating component may include establishing one or more crystalline structures of the alloy of Cobalt Chromium. Securing the bone anchoring component joint-facing side to the articulating component bone-facing side may include heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to a bonding temperature far below melting temperatures of Cobalt and Chromium, so as to avoid significantly modifying the crystalline structures.
- the method may further include, prior to heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature, applying a paste to one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side.
- the paste may include a gelatin and/or glycerin and Titanium nanoparticles.
- the method may further include, after applying the paste on one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side, and prior to heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature, assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side, and pressing the bone anchoring component joint-facing side and the articulating component bone-facing side together.
- Heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature may include, with the bone anchoring component joint-facing side and the articulating component bone-facing side pressed together, heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side in a two-step heating process to about 500° C. to debind the gelatin/glycerin from the paste and melt the Titanium nanoparticles.
- the debinding process may be at a temperature below 500° C. and after the gelatin/glycerin is sufficiently removed by debinding, the components may then be heated to about 500° C. for Titanium nanoparticle melting.
- a laser process may be used to melt the metal of the bone anchoring component and the articulating component along the perimeter and/or along the seams.
- a metal powder and binder mixture may be placed along the parameter and seams between the bone anchoring and articulating components and subsequently melted with a laser. The re-solidified metal powder may bond the bone anchoring component and the articulating component together.
- a method may be designed to manufacture a prosthesis for replacing an articular surface on a bone.
- the method may include casting metals comprising at least Cobalt and Chromium to form an articulating component with an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape.
- the method may further include direct metal laser sintering Titanium to form a bone anchoring component with a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side with a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores.
- the method may further include applying a paste containing Titanium nanoparticles to at least one of the bone anchoring component joint-facing side and the articulating component bone-facing side, assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side, and heating the paste to a bonding temperature sufficient to commence melting of the Titanium nanoparticles to secure the bone anchoring component joint-facing side to the articulating component bone-facing side.
- the method may further include anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side, and, after assembling the articulating component and the bone anchoring component, pressing the articulating component and the bone anchoring component together.
- the paste may further include gelatin and/or glycerin. Heating the paste to the bonding temperature may include, with the articulating component and the bone anchoring component pressed together, heating at least the bone anchoring component joint-facing side and the articulating component to a temperature below 500° C. to debind the gelatin/glycerin, and then heating the bone anchoring component joint-facing side to about 500° C. to melt the Titanium nanoparticles, and changing at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
- FIG. 1 is a perspective view of a knee arthroplasty system according to one embodiment.
- FIG. 2 is an exploded, perspective view of the femoral prosthesis of the knee arthroplasty system of FIG. 1 .
- FIG. 3 is an exploded, perspective view, from a different viewpoint, of the femoral prosthesis of the knee arthroplasty system of FIG. 1 .
- FIG. 4 is an exploded, perspective view of the tibial prosthesis of the knee arthroplasty system of FIG. 1 .
- FIG. 5 is an exploded, perspective view, from a different viewpoint, of the tibial prosthesis of the knee arthroplasty system of FIG. 1 .
- phrases “connected to,” “coupled to” and “in communication with” refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interaction. Two components may be functionally coupled to each other even though they are not in direct contact with each other.
- the term “abutting” refers to items that are in direct physical contact with each other, although the items may not necessarily be attached together.
- the phrase “fluid communication” refers to two features that are connected such that a fluid within one feature is able to pass into the other feature.
- the systems and methods of the present disclosure may be used in connection with a wide variety of implant types.
- the systems and methods disclosed herein may have particular applicability to implants that benefit from having disparate materials, such as porous materials for bone engagement and hard or nonporous materials for articulation.
- the systems and methods set forth herein may be of particular benefit for joint replacement implants.
- This disclosure focuses on knee arthroplasty implants; however, those of skill in the art will recognize that it may readily be applied to other joint arthroplasty implants, or to implants designed for other purposes besides joint arthroplasty.
- FIG. 1 is a perspective view of a knee arthroplasty system, or system 100 , according to one embodiment.
- the system 100 may be designed to replace the natural articulating surfaces of a knee joint, and may thus have a femoral prosthesis 102 and a tibial prosthesis 104 .
- the system 100 may be designed to replace only the femoral or tibial articulating surfaces, and may thus include only the femoral prosthesis 102 or the tibial prosthesis 104 .
- the femoral prosthesis 102 and the tibial prosthesis 104 may each have an articulating component with replacement articulating surfaces, and a bone anchoring component secured to the articulating component to secure the articulating component to the underlying bone.
- the femoral prosthesis 102 may have a femoral articulating component 110 and a femoral bone anchoring component 112 .
- the tibial prosthesis 104 may have a tibial articulating component 114 and a tibial bone anchoring component 116 .
- Each of the aforementioned articulating components and bone anchoring components may have a joint-facing side and a bone-facing side.
- the femoral articulating component 110 may have a joint-facing side 120 and a bone-facing side 122
- the femoral bone anchoring component 112 may have a joint-facing side 124 and a bone-facing side 126
- the tibial articulating component 114 may have a joint-facing side 130 and a bone-facing side 132
- the tibial bone anchoring component 116 may have a joint-facing side 134 and a bone-facing side 136 .
- the bone-facing side 122 of the femoral articulating component 110 may have a shape that matches the shape of the joint-facing side 124 of the femoral bone anchoring component 112 , and may be secured to the joint-facing side 124 of the femoral bone anchoring component 112 in a manner that will be set forth in greater detail subsequently.
- the bone-facing side 132 of the tibial articulating component 114 may have a shape that matches the shape of the joint-facing side 134 of the tibial bone anchoring component 116 , and may be secured to the joint-facing side 134 of the tibial bone anchoring component 116 in a manner that will be set forth in greater detail subsequently.
- the joint-facing side 120 of the femoral articulating component 110 may have a first articulating surface 140 and a second articulating surface 142 , which are shaped to mimic the shapes of the natural articulating surfaces on the end of the femur.
- the shapes depicted in FIG. 1 are merely exemplary; according to alternative embodiments, any articulating surface shape known in the art may be used.
- the bone-facing side 126 of the femoral bone anchoring component 112 may have one or more features that enhance engagement of the femoral bone anchoring component 112 with the underlying bone.
- the bone-facing side 126 of the femoral bone anchoring component 112 may have a pair of posts 150 that protrude from the bone-facing side 126 of the femoral bone anchoring component 112 .
- other bone anchoring features (not shown), as known in the art, may be used in addition to or in the alternative to the posts 150 .
- the joint-facing side 130 of the tibial articulating component 114 may also have a first articulating surface 180 and a second articulating surface 182 .
- the first articulating surface 140 may articulate with the first articulating surface 180
- the second articulating surface 142 may articulate with the second articulating surface 182 .
- the articulation of the femoral articulating component 110 with the tibial articulating component 114 may be designed to mimic that of the natural knee joint.
- the bone-facing side 136 of the tibial bone anchoring component 116 may have a plurality of posts 190 that protrude into the bone from the remainder of the bone-facing side 136 .
- other bone anchoring features (not shown), as known in the art, may be used in addition to or in the alternative to the posts 190 .
- FIG. 2 is an exploded, perspective view of the femoral prosthesis 102 of the system 100 of FIG. 1 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may optionally be manufactured separately from each other. Accordingly, different manufacturing processes may be used to form the femoral articulating component 110 and the femoral bone anchoring component 112 . This may advantageously enable the use of materials and/or processes for each of the femoral articulating component 110 and the femoral bone anchoring component 112 that are best suited for the role to be performed.
- the femoral articulating component 110 may be designed to endure cyclical loading in friction and compression. Accordingly, high-strength and/or low-wear materials and surface properties may be desired. Accordingly, the femoral articulating component 110 may be made of a relatively hard material such as an alloy of Cobalt Chromium (“Cobalt Chrome,”). Specifically, the femoral articulating component 110 may be made of an alloy of Cobalt Chromium Molybdenum (CoCrMo). A manufacturing process such as casting may be used. In some embodiments, the first articulating surface 140 and the second articulating surface 142 may be specially processed in a manner that increases their hardness and/or wear resistance.
- the femoral bone anchoring component 112 may be designed to provide high-strength fixation of the femoral articulating component 110 to the underlying bone. It may be desirable for the femoral bone anchoring component 112 to have a porous structure that encourages bone in-growth. Accordingly, the femoral bone anchoring component 112 may be formed of a metal such as Titanium, or specifically, direct metal laser sintered (“DMLS”) Titanium. The femoral bone anchoring component 112 may be formed via an additive manufacturing method such as 3D printing. Such manufacturing methods may facilitate the creation of a porous structure, particularly on the bone-facing side 126 of the femoral bone anchoring component 112 .
- DMLS direct metal laser sintered
- the femoral bone anchoring component 112 may be made such that the porosity varies in a gradient through the thickness of the femoral bone anchoring component 112 .
- the bone-facing side 126 of the femoral bone anchoring component 112 may be made more porous to facilitate bone in-growth, while the joint-facing side 124 of the femoral bone anchoring component 112 may be made less porous to enhance attachment of the joint-facing side 124 to the bone-facing side 122 of the femoral articulating component 110 .
- the joint-facing side 124 may be made substantially solid (i.e., nonporous) to enhance adhesion to the bone-facing side 122 of the femoral articulating component 110 , while the bone-facing side 126 may be highly porous.
- the bone-facing side 122 of the femoral articulating component 110 may have an anterior portion 200 , a posterior portion 202 , and a distal portion 204 .
- the anterior portion 200 may be located on the anterior side of the knee
- the posterior portion 202 may be located on the posterior side of the knee
- the distal portion 204 may be located at the distal end of the femur.
- the distal portion 204 may be divided into three faces: an anterior-distal face 206 , a posterior-distal face 208 , and a distal face 210 .
- the anterior-distal face 206 may reside between the anterior portion 200 and the distal face 210
- the posterior-distal face 208 may be reside between the posterior portion 202 and the distal face 210
- the posts 150 may protrude from the distal face 210 .
- the posts 150 may all protrude in a cephalad direction so that these features can penetrate the bone, helping to anchor the femoral articulating component 110 on the distal end of the femur (not shown).
- the posts 150 may optionally be shaped to facilitate entry into and/or compaction of the bone.
- the bone surrounding the posts 150 in their implanted state may be compacted and/or strengthened.
- the bone-facing side 122 of the femoral articulating component 110 may have a peripheral ridge 220 that defines an interior recess 222 .
- the shape of the interior recess 222 may closely match that of the joint-facing side 124 of the femoral bone anchoring component 112 so that the joint-facing side 124 of the femoral bone anchoring component 112 can be secured to the interior recess 222 .
- the bone-facing side 126 of the femoral bone anchoring component 112 may lie substantially flush with the peripheral ridge 220 of the bone-facing side 122 of the femoral articulating component 110 .
- the bone-facing side 126 of the femoral bone anchoring component 112 may be treated to enhance porosity and/or bone in-growth.
- the bone-facing side 126 of the femoral bone anchoring component 112 may be processed via a process such as anodizing to form Titanium Dioxide nanotubes on the bone-facing side 126 .
- the bone-facing side 126 may be anodized in a Fluoride electrolyte, as set forth in U.S. application Ser. No. 11/913,062, filed Jun. 10, 2008 and entitled “Compositions Comprising Nanostructures for Cell, Tissue and Artificial Organ Growth, and Methods for Making and Using Same, now U.S. Pat. No. 8,414,908, which is incorporated by reference as though set forth herein in its entirety.
- the result may be the formation of a surface layer 230 of Titanium Dioxide nanotubes on the bone-facing side 126 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may be secured together in a variety of ways.
- One exemplary attachment method will be set forth as follows. Those of skill in the art will recognize that various steps set forth below may be omitted, replaced with alternative steps, and/or supplemented with additional steps not specifically provided herein. Further, the following steps are not limited to knee implants, but may be used in connection with any implant having an articulating component and a bone engagement component.
- a paste 240 may be made from nanoparticles of a metal such as commercially pure Titanium.
- the nanoparticles may be formed in a variety of ways.
- Titanium nanoparticles may be made by ball milling a Titanium halide such as Titanium Chloride, with a metal reactant such as Magnesium.
- a metal reactant such as Magnesium.
- other metals such as those of group 1 and group 2
- the mechanical action and formation of salt byproduct may prevent particle growth and produce fine particles.
- the salt byproduct may be removed via solvation in water or an aprotic solvent with a high dielectric constant, such as formaldehyde. Further details may be found in Blair, R. G., E. G. Gillan, N. K. B.
- the result may be formation of nanoparticles of Titanium.
- the nanoparticles may be less than 20 nm in cross-sectional size, and need not be spherical but may instead be flake-shaped.
- the nanoparticles may thus have a melting temperature much lower than that of bulk Titanium.
- it may be desirable to provide the nanoparticles in a fairly tight Gaussian distribution, for example, 15 nm average size, +/ ⁇ 5 nm. Even a few particles greater than 25 nm in size may cause the melting temperature to rise.
- the low melting temperature may help the nanoparticles to melt into the adjoining material (for example, CrCo and Ti) and mechanically bond therewith, rather than diffusion bonding, as will be discussed subsequently.
- the Titanium nanoparticles may be added to material such as a gelatin and/or glycerin to form the paste 240 .
- the paste may be applied to one or both of the surfaces to be secured together, which, for the femoral prosthesis 102 , may be the joint-facing side 124 of the femoral bone anchoring component 112 and the interior recess 222 of the bone-facing side 122 of the femoral articulating component 110 .
- the paste 240 depicted in FIG. 2 , on the joint-facing side 124 and the interior recess 222 is merely exemplary; it may be advantageous to spread the paste 240 over substantially the entire surface of the joint-facing side 124 or the interior recess 222 .
- the paste 240 may be applied in a variety of ways, such as spraying the surface to be coated, immersing the surface to be coated in a quantity of the paste, and/or spreading the paste 240 on the surface with a brush or other implement.
- the use of the gelatin and/or glycerin may facilitate adhesion of the paste 240 to the joint-facing side 124 and the bone-facing side 122 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may then be assembled together such that the joint-facing side 124 of the femoral bone anchoring component 112 is in contact with the bone-facing side 122 of the femoral articulating component 110 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may be compressed together. In some embodiments, this may be done by positioning the femoral articulating component 110 above the femoral bone anchoring component 112 , so that the weight of the femoral articulating component 110 urges the femoral articulating component 110 against the femoral bone anchoring component 112 .
- a carbon fixture or other implement may be used to urge the femoral articulating component 110 and the femoral bone anchoring component 112 together.
- the femoral articulating component 110 and the femoral bone anchoring component 112 may then be placed into a vacuum furnace or other heating implement. If desired, the femoral articulating component 110 and the femoral bone anchoring component 112 may continue to be compressed together as these parts are inserted into the furnace and heated. The furnace may then be used to heat the femoral articulating component 110 and the femoral bone anchoring component 112 .
- the gelatin and/or glycerin may be burned away (debind process), and Carbon may be outgassed from the partial pressure vacuum furnace via an inert carrier gas.
- the Titanium nanoparticles may be left with air between their spheres.
- the furnace may be used to further heat the femoral articulating component 110 and the femoral bone anchoring component 112 to a bonding temperature of about 500° C., at which the Titanium nanoparticles may begin to melt, securing the joint-facing side 124 of the femoral bone anchoring component 112 to the bone-facing side 122 of the femoral articulating component 110 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may then be removed from the furnace and allowed to cool.
- the Titanium Dioxide nanotubes may turn into anatase. This may be advantageous because, when compared with amorphous Titanium Dioxide, anatase may have greater strength and superior bone bonding characteristics.
- the surface properties of the bone-facing side 126 of the femoral bone anchoring component 112 may be enhanced by the process used to bond the femoral bone anchoring component 112 to the femoral articulating component 110 .
- the maximum temperature of this process may be the bonding temperature, which may be much lower than the melting temperatures of the significant constituent metals of which the femoral articulating component 110 is formed.
- the melting temperature of Cobalt is 1,995° C.
- the melting temperature of Chromium is 1,907° C.
- the melting temperature of Molybdenum is 2,623° C.
- the bonding process used to secure the femoral articulating component 110 to the femoral bone anchoring component 112 may not change the crystalline structure of the femoral bone anchoring component 112 , as determined by the manufacturing process (for example, casting) used to form the femoral bone anchoring component 112 .
- formation of brittle alloys may be avoided, which may occur in known processes in which conventional Titanium is diffusion bonded to Cobalt Chromium Molybdenum.
- Nanoparticles of metals often have melting temperatures lower than those of the corresponding bulk metals; accordingly, a wide variety of nanoparticles, including Titanium, Cobalt, and Chromium nanoparticles, may be used. Additionally or alternatively, metals with lower melting temperatures than Titanium, Cobalt, and Chromium may be used in bulk, rather than nanoparticle, form.
- Nitinol has a melting temperature of about 1400° C., which is also lower than the melting temperatures of Titanium, Cobalt, and Chromium.
- the paste 240 in some embodiments may include a Nitinol powder, which need not be in the form of nanoparticles.
- the bond formed between the joint-facing side 124 of the femoral bone anchoring component 112 and the bone-facing side 122 of the femoral articulating component 110 may be a physical bond rather than a metallurgical bond.
- the Titanium nanoparticles may flow into surface irregularities in the joint-facing side 124 of the femoral bone anchoring component 112 and/or the bone-facing side 122 of the femoral articulating component 110 so that, when the Titanium nanoparticles re-freeze, they secure the femoral articulating component 110 and the femoral bone anchoring component 112 together. Avoidance of a metallurgical bond is advantageous in that such bonds can disrupt the crystalline structure of the materials being bonded.
- the low bonding temperature of the method set forth herein has many advantages, and may provide the femoral prosthesis 102 with enhanced wear resistance and/or bone adhesion.
- a second attachment method may be used in addition to or in the alternative to the foregoing.
- the femoral bone anchoring component 112 may be placed in the interior recess 222 of the bone-facing side 122 of the femoral articulating component 110 .
- a laser may be used to melt the metal of both components together along the perimeter and/or along the seams between the femoral bone anchoring component 112 and the femoral articulating component 110 .
- a third attachment method may be used in addition to or in the alternative to either or both of the foregoing.
- a metallic powder and binder mixture may be placed along the perimeter and/or the seams of the femoral bone anchoring component 112 prior to placement of the femoral bone anchoring component 112 in the interior recess 222 of the bone-facing side 122 of the femoral articulating component 110 .
- a laser may be used to melt the metal powder and binder mixture along the perimeter and/or the seams. The re-solidified metal may bond the femoral bone anchoring component 112 and the femoral articulating component 110 together.
- the same method may be used to secure the tibial articulating component 114 to the tibial bone anchoring component 116 .
- bonding methods may be used not just for knee implants, but for other types of implants, and in particular, orthopedic implants in which an articulating component is to be secured to a bone anchoring component.
- the method set forth above may be effective for relatively smooth surfaces.
- the surfaces to be bonded together may have features that facilitate and/or enhance the results of the bonding process.
- the bone-facing side 122 of the femoral articulating component 110 may have features that cooperate with corresponding features (shown in FIG. 4 ) on the joint-facing side 124 of the femoral bone anchoring component 112 to help align the femoral articulating component 110 with the femoral bone anchoring component 112 and/or add mechanical fastening to the bonding described above.
- These features of the bone-facing side 122 may include, by way of example, a pair of post bosses 250 .
- FIG. 3 is an exploded, perspective view, from a different viewpoint, of the femoral prosthesis 102 of the system 100 of FIG. 1 .
- the joint-facing side 124 of the femoral bone anchoring component 112 and the joint-facing side 120 of the femoral articulating component 110 are more clearly visible.
- the joint-facing side 124 of the femoral bone anchoring component 112 may have features that cooperate with the post bosses 250 of the bone-facing side 122 of the femoral articulating component 110 depicted in FIG. 2 .
- These features may include, for example, post bores 350 .
- Each of the post bores 350 may reside in the interior of one of the posts 150 .
- the post bores 350 may be shaped to receive the post bosses 250 .
- the post bosses 250 may each be tapered to facilitate insertion into the post bores 350 .
- the features of the bone-facing side 122 may be received by these features of the joint-facing side 124 with some interference, which may cooperate with the bond described above to enhance attachment of the bone-facing side 122 to the joint-facing side 124 .
- the compression may be sufficient to urge the post bosses 250 into the post bores 350 .
- the heat applied to the femoral articulating component 110 and the femoral bone anchoring component 112 may cause thermal expansion eases insertion of the post bosses 250 into the post bores 350 .
- the femoral articulating component 110 may be made such that the femoral articulating component 110 has higher thermal expansion than the femoral bone anchoring component 112 .
- the femoral articulating component 110 and the femoral bone anchoring component 112 may be cooled, allowing the bores to tighten around the bosses.
- positive and/or negative features may be used.
- the positive features may be on the joint-facing side 124 of the femoral bone anchoring component 112
- the negative features may be on the bone-facing side 122 of the femoral articulating component 110 .
- FIG. 4 is an exploded, perspective view of the tibial prosthesis 104 of the system 100 of FIG. 1 .
- the tibial articulating component 114 and the tibial bone anchoring component 116 may optionally be manufactured separately from each other. Accordingly, different manufacturing processes may be used to form the tibial articulating component 114 and the tibial bone anchoring component 116 .
- the tibial articulating component 114 may be formed via casting
- the tibial bone anchoring component 116 may be formed via additive manufacturing such as 3D printing.
- the tibial articulating component 114 may be made of Cobalt Chromium, or Cobalt Chromium Molybdenum.
- the tibial bone anchoring component 116 may be made of DMLS Titanium.
- a gradient of porosities may be present in the tibial bone anchoring component 116 , with greater porosity on the bone-facing side 136 , and lesser porosity on the joint-facing side 134 .
- the joint-facing side 134 may be made substantially nonporous to enhance adhesion to the tibial articulating component 114 , and the bone-facing side 136 may have a high level of porosity to promote bone in-growth.
- the bone-facing side 132 of the tibial articulating component 114 may have a central plateau 400 that extends toward the tibial bone anchoring component 116 , and a peripheral recess 402 that encircles the central plateau 400 and is recessed from the tibial bone anchoring component 116 .
- the joint-facing side 134 of the tibial bone anchoring component 116 may have a shape that is complementary to that of the bone-facing side 132 of the tibial articulating component 114 .
- the joint-facing side 134 may have a peripheral ridge 410 that encircles an interior recess 412 .
- An alcove 414 may extend into the peripheral ridge 410 , from the space above the interior recess 412 .
- the tibial articulating component 114 and the tibial bone anchoring component 116 may be secured together by the same bonding process described above in connection with the femoral articulating component 110 and the femoral bone anchoring component 112 of the femoral prosthesis 102 , or with a modified version of such a bonding process.
- FIG. 4 depicts the exemplary application of the paste 240 to the interior recess 412 of the joint-facing side 134 of the tibial bone anchoring component 116 .
- FIG. 5 is an exploded, perspective view, from a different viewpoint, of the tibial prosthesis 104 of the system 100 of FIG. 1 .
- the central plateau 400 of the bone-facing side 132 of the tibial articulating component 114 may have a lip 500 that protrudes anteriorly.
- the lip 500 may protrude into the alcove 414 depicted in FIG. 4 . Engagement of the lip 500 and the alcove 414 may further help to hold the anterior portions of the tibial articulating component 114 and the tibial bone anchoring component 116 together.
- FIG. 5 also depicts the bone-facing side 136 of the tibial bone anchoring component 116 in greater detail.
- Four of the posts 190 may be present on the bone-facing side 136 , and may help enhance the level of engagement of the bone-facing side 136 with the underlying bone, and in particular, with the cortical bone at the proximal end of the tibia.
- the posts 190 may also increase the surface area of the bone-facing side 136 in contact with the bone of the tibia, thereby further enhancing the potential for bone cement bonding and/or bone in-growth between the tibia and the bone-facing side 136 .
- the tibial bone anchoring component 116 may be processed as described above in the description of the femoral bone anchoring component 112 , such that the tibial bone anchoring component 116 has a surface layer 230 formed of Titanium Dioxide nanotubes. Such a surface layer 230 may further enhance bone in-growth to further secure the bone-facing side 136 to the bone of the tibia.
- the tibial articulating component 114 and the tibial bone anchoring component 116 may be secured together through the use of a method like that set forth in the description of the femoral articulating component 110 and the femoral bone anchoring component 112 .
- the paste 240 may be applied to the bone-facing side 132 of the tibial articulating component 114 and/or to the joint-facing side 134 of the tibial bone anchoring component 116 .
- Any methods disclosed herein comprise one or more steps or actions for performing the described method.
- the method steps and/or actions may be interchanged with one another.
- the order and/or use of specific steps and/or actions may be modified.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Heart & Thoracic Surgery (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- Biomedical Technology (AREA)
- Surgery (AREA)
- Transplantation (AREA)
- Physical Education & Sports Medicine (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Dentistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Molecular Biology (AREA)
- Medical Informatics (AREA)
- Manufacturing & Machinery (AREA)
- Chemical & Material Sciences (AREA)
- Materials Engineering (AREA)
- Plasma & Fusion (AREA)
- Physics & Mathematics (AREA)
- Prostheses (AREA)
- Surgical Instruments (AREA)
- Composite Materials (AREA)
- Mechanical Engineering (AREA)
Abstract
A prosthesis may have an articulating component formed via casting and a 3D printed bone anchoring component with a joint-facing side and a bone-facing side. The bone-facing side may have a bone engagement surface with a porous structure with pores selected to facilitate in-growth of the bone into the pores. The bone facing side may further have a surface layer of Titanium Dioxide nanotubes. The joint-facing side may be secured to the articulating component by melting Titanium nanoparticles at a temperature below the melting temperatures of the major constituents of the articulating component and/or the bone anchoring component, such as Cobalt, Chromium, and/or Titanium, so as to avoid significantly modifying the crystalline structures of the articulating component and/or the bone anchoring component. The melting temperature of the Titanium nanoparticles may be about 500° C.
Description
- This application is a continuation of U.S. patent application Ser. No. 15/625,802, filed Jun. 16, 2017, entitled “Composite Joint Arthroplasty Systems and Methods”, which claims priority to U.S. Provisional Application Ser. No. 62/466,249 filed on Mar. 2, 2017, entitled “Composite Joint Arthroplasty Systems and Methods”, which are incorporated herein by reference as though set forth in their entirety.
- The present disclosure relates to surgical systems and methods. More specifically, the present disclosure relates to implants and related methods for joint arthroplasty.
- Joint arthroplasty procedures are surgical procedures in which one or more articulating surfaces of a joint are replaced with prosthetic articulating surfaces. Such procedures are becoming increasingly commonplace, for many joints of the body.
- For a successful joint arthroplasty, it is important that the implants remain in place and maintain the necessary wear characteristics. Further, it is desirable for the arthroplasty procedure to be carried out quickly and smoothly. Many existing joint arthroplasty implants and methods are time-consuming to implant, do not form a sufficient attachment to the underlying bone, or leave excessive wear debris.
- The various systems and methods of the present disclosure have been developed in response to the present state of the art, and in particular, in response to the problems and needs in the art that have not yet been fully solved by currently available joint arthroplasty systems and methods. The systems and methods of the present disclosure may provide joint implants and instruments that provide enhanced bone fixation, less wear debris, and/or streamlined implantation.
- According to some embodiments, a prosthesis may be designed to replace an articular surface on bone. The prosthesis may have an articulating component formed via casting, and a bone anchoring component having a 3D printed structure. The articulating component may have an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape. The bone anchoring component may have a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side. The bone anchoring component joint-facing side may be secured to the articulating component bone-facing side. The bone anchoring component bone-facing side may have a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores.
- The bone anchoring component may be formed of DMLS (direct metal laser sintered) Titanium, and the 3D printed structure may have a porous structure. The porous structure may have a lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side. The bone anchoring component joint-facing side may have a near solid structure with little or no porosity.
- The bone anchoring component bone-facing side may have a surface layer of Titanium Dioxide nanotubes formed via anodization. The Titanium Dioxide nanotubes may have an anatase structure.
- The articulating component may be formed of an alloy of Cobalt Chromium. The alloy of Cobalt Chromium may have one or more crystalline structures established by a casting process used to form the articulating component. The bone anchoring component joint-facing side may be secured to the articulating component bone-facing side via a bonding process occurring at a bonding temperature far below melting temperatures of Cobalt and Chromium, such the crystalline structures are not significantly modified by the bonding process. The bonding process may occur at a bonding temperature of about 500° C. The prosthesis may further have a bonding zone, between the bone anchoring component joint-facing side and the articulating component bone-facing side, formed of melted and re-solidified Titanium nanoparticles.
- The bone anchoring component joint-facing side may additionally or alternatively be secured to the articulating component bone-facing side via a laser welding process around the perimeter and/or along the seams of the two components. Additionally or alternatively, the two components may also be laser welded along the perimeter and/or seams with the addition of a metallic powder and binder mixture along the weld lines. Specifically, a metal powder and binder mixture may be placed along the weld lines and subsequently melted with a laser. The re-solidified metal may bond the bone anchoring component and the articulating component together. The metallic powder and binder mixture may include titanium powder and a binder consisting of gelatin, glycerin and/or PVA. The metallic powder may additionally or alternatively include a cobalt and chromium powder and a binder consisting of gelatin, glycerin or PVA.
- According to some embodiments, a method may be designed for manufacturing a prosthesis for replacing an articular surface on a bone. The method may include casting an articulating component with an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape. The method may further include 3D printing a bone anchoring component with a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side with a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores. The method may further include securing the bone anchoring component joint-facing side to the articulating component bone-facing side.
- 3D printing the bone anchoring component may include direct metal laser sintering Titanium to form a porous structure. Forming the porous structure may include providing lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side.
- The method may further include anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side. The method may further include heating the bone anchoring component to a temperature sufficient to change at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
- Casting the articulating component may include casting the articulating component from an alloy of Cobalt Chromium. Casting the articulating component may include establishing one or more crystalline structures of the alloy of Cobalt Chromium. Securing the bone anchoring component joint-facing side to the articulating component bone-facing side may include heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to a bonding temperature far below melting temperatures of Cobalt and Chromium, so as to avoid significantly modifying the crystalline structures. The method may further include, prior to heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature, applying a paste to one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side. The paste may include a gelatin and/or glycerin and Titanium nanoparticles.
- The method may further include, after applying the paste on one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side, and prior to heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature, assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side, and pressing the bone anchoring component joint-facing side and the articulating component bone-facing side together. Heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature may include, with the bone anchoring component joint-facing side and the articulating component bone-facing side pressed together, heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side in a two-step heating process to about 500° C. to debind the gelatin/glycerin from the paste and melt the Titanium nanoparticles. The debinding process may be at a temperature below 500° C. and after the gelatin/glycerin is sufficiently removed by debinding, the components may then be heated to about 500° C. for Titanium nanoparticle melting.
- In other attachment methods, a laser process may be used to melt the metal of the bone anchoring component and the articulating component along the perimeter and/or along the seams. Additionally or alternatively, a metal powder and binder mixture may be placed along the parameter and seams between the bone anchoring and articulating components and subsequently melted with a laser. The re-solidified metal powder may bond the bone anchoring component and the articulating component together.
- Further, according to some embodiments, a method may be designed to manufacture a prosthesis for replacing an articular surface on a bone. The method may include casting metals comprising at least Cobalt and Chromium to form an articulating component with an articulating component joint-facing side with an articular surface, and an articulating component bone-facing side with a bone-facing shape. The method may further include direct metal laser sintering Titanium to form a bone anchoring component with a bone anchoring component joint-facing side with a joint-facing shape that is complementary to the bone-facing shape, and a bone anchoring component bone-facing side with a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores. The method may further include applying a paste containing Titanium nanoparticles to at least one of the bone anchoring component joint-facing side and the articulating component bone-facing side, assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side, and heating the paste to a bonding temperature sufficient to commence melting of the Titanium nanoparticles to secure the bone anchoring component joint-facing side to the articulating component bone-facing side.
- The method may further include anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side, and, after assembling the articulating component and the bone anchoring component, pressing the articulating component and the bone anchoring component together. The paste may further include gelatin and/or glycerin. Heating the paste to the bonding temperature may include, with the articulating component and the bone anchoring component pressed together, heating at least the bone anchoring component joint-facing side and the articulating component to a temperature below 500° C. to debind the gelatin/glycerin, and then heating the bone anchoring component joint-facing side to about 500° C. to melt the Titanium nanoparticles, and changing at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
- These and other features and advantages of the present disclosure will become more fully apparent from the following description and appended claims, or may be learned by the practice of the systems and methods set forth hereinafter.
- Exemplary embodiments of the disclosure will become more fully apparent from the following description and appended claims, taken in conjunction with the accompanying drawings. Understanding that these drawings depict only exemplary embodiments and are, therefore, not to be considered limiting of the scope of the appended claims, the exemplary embodiments of the present disclosure will be described with additional specificity and detail through use of the accompanying drawings in which:
-
FIG. 1 is a perspective view of a knee arthroplasty system according to one embodiment. -
FIG. 2 is an exploded, perspective view of the femoral prosthesis of the knee arthroplasty system ofFIG. 1 . -
FIG. 3 is an exploded, perspective view, from a different viewpoint, of the femoral prosthesis of the knee arthroplasty system ofFIG. 1 . -
FIG. 4 is an exploded, perspective view of the tibial prosthesis of the knee arthroplasty system ofFIG. 1 . -
FIG. 5 is an exploded, perspective view, from a different viewpoint, of the tibial prosthesis of the knee arthroplasty system ofFIG. 1 . - Exemplary embodiments of the disclosure will be best understood by reference to the drawings, wherein like parts are designated by like numerals throughout. It will be readily understood that the components of the disclosure, as generally described and illustrated in the Figures herein, could be arranged and designed in a wide variety of different configurations. Thus, the following more detailed description of the embodiments of the apparatus, system, and method, as represented in
FIGS. 1 through 5 , is not intended to limit the scope of the claims, as claimed, but is merely representative exemplary of exemplary embodiments. - The phrases “connected to,” “coupled to” and “in communication with” refer to any form of interaction between two or more entities, including mechanical, electrical, magnetic, electromagnetic, fluid, and thermal interaction. Two components may be functionally coupled to each other even though they are not in direct contact with each other. The term “abutting” refers to items that are in direct physical contact with each other, although the items may not necessarily be attached together. The phrase “fluid communication” refers to two features that are connected such that a fluid within one feature is able to pass into the other feature.
- The word “exemplary” is used herein to mean “serving as an example, instance, or illustration.” Any embodiment described herein as “exemplary” is not necessarily to be construed as preferred or advantageous over other embodiments. While the various aspects of the embodiments are presented in drawings, the drawings are not necessarily drawn to scale unless specifically indicated.
- The systems and methods of the present disclosure may be used in connection with a wide variety of implant types. The systems and methods disclosed herein may have particular applicability to implants that benefit from having disparate materials, such as porous materials for bone engagement and hard or nonporous materials for articulation. Thus, the systems and methods set forth herein may be of particular benefit for joint replacement implants. This disclosure focuses on knee arthroplasty implants; however, those of skill in the art will recognize that it may readily be applied to other joint arthroplasty implants, or to implants designed for other purposes besides joint arthroplasty.
-
FIG. 1 is a perspective view of a knee arthroplasty system, orsystem 100, according to one embodiment. Thesystem 100 may be designed to replace the natural articulating surfaces of a knee joint, and may thus have afemoral prosthesis 102 and atibial prosthesis 104. In some embodiments, thesystem 100 may be designed to replace only the femoral or tibial articulating surfaces, and may thus include only thefemoral prosthesis 102 or thetibial prosthesis 104. - The
femoral prosthesis 102 and thetibial prosthesis 104 may each have an articulating component with replacement articulating surfaces, and a bone anchoring component secured to the articulating component to secure the articulating component to the underlying bone. Specifically, thefemoral prosthesis 102 may have a femoral articulatingcomponent 110 and a femoralbone anchoring component 112. Similarly, thetibial prosthesis 104 may have a tibial articulatingcomponent 114 and a tibialbone anchoring component 116. - Each of the aforementioned articulating components and bone anchoring components may have a joint-facing side and a bone-facing side. Thus, the
femoral articulating component 110 may have a joint-facingside 120 and a bone-facingside 122, and the femoralbone anchoring component 112 may have a joint-facingside 124 and a bone-facingside 126. Similarly, thetibial articulating component 114 may have a joint-facingside 130 and a bone-facingside 132, and the tibialbone anchoring component 116 may have a joint-facingside 134 and a bone-facingside 136. - The bone-facing
side 122 of the femoral articulatingcomponent 110 may have a shape that matches the shape of the joint-facingside 124 of the femoralbone anchoring component 112, and may be secured to the joint-facingside 124 of the femoralbone anchoring component 112 in a manner that will be set forth in greater detail subsequently. Similarly, the bone-facingside 132 of thetibial articulating component 114 may have a shape that matches the shape of the joint-facingside 134 of the tibialbone anchoring component 116, and may be secured to the joint-facingside 134 of the tibialbone anchoring component 116 in a manner that will be set forth in greater detail subsequently. - The joint-facing
side 120 of the femoral articulatingcomponent 110 may have a first articulatingsurface 140 and a second articulatingsurface 142, which are shaped to mimic the shapes of the natural articulating surfaces on the end of the femur. The shapes depicted inFIG. 1 are merely exemplary; according to alternative embodiments, any articulating surface shape known in the art may be used. - The bone-facing
side 126 of the femoralbone anchoring component 112 may have one or more features that enhance engagement of the femoralbone anchoring component 112 with the underlying bone. For example, the bone-facingside 126 of the femoralbone anchoring component 112 may have a pair ofposts 150 that protrude from the bone-facingside 126 of the femoralbone anchoring component 112. Optionally, other bone anchoring features (not shown), as known in the art, may be used in addition to or in the alternative to theposts 150. - The joint-facing
side 130 of thetibial articulating component 114 may also have a first articulatingsurface 180 and a second articulatingsurface 182. After implantation of thefemoral prosthesis 102 and thetibial prosthesis 104, the first articulatingsurface 140 may articulate with the first articulatingsurface 180, and the second articulatingsurface 142 may articulate with the second articulatingsurface 182. The articulation of the femoral articulatingcomponent 110 with thetibial articulating component 114 may be designed to mimic that of the natural knee joint. - The bone-facing
side 136 of the tibialbone anchoring component 116 may have a plurality ofposts 190 that protrude into the bone from the remainder of the bone-facingside 136. Optionally, other bone anchoring features (not shown), as known in the art, may be used in addition to or in the alternative to theposts 190. -
FIG. 2 is an exploded, perspective view of thefemoral prosthesis 102 of thesystem 100 ofFIG. 1 . The femoral articulatingcomponent 110 and the femoralbone anchoring component 112 may optionally be manufactured separately from each other. Accordingly, different manufacturing processes may be used to form thefemoral articulating component 110 and the femoralbone anchoring component 112. This may advantageously enable the use of materials and/or processes for each of the femoral articulatingcomponent 110 and the femoralbone anchoring component 112 that are best suited for the role to be performed. - For example, the
femoral articulating component 110 may be designed to endure cyclical loading in friction and compression. Accordingly, high-strength and/or low-wear materials and surface properties may be desired. Accordingly, thefemoral articulating component 110 may be made of a relatively hard material such as an alloy of Cobalt Chromium (“Cobalt Chrome,”). Specifically, thefemoral articulating component 110 may be made of an alloy of Cobalt Chromium Molybdenum (CoCrMo). A manufacturing process such as casting may be used. In some embodiments, the first articulatingsurface 140 and the second articulatingsurface 142 may be specially processed in a manner that increases their hardness and/or wear resistance. - Conversely, the femoral
bone anchoring component 112 may be designed to provide high-strength fixation of the femoral articulatingcomponent 110 to the underlying bone. It may be desirable for the femoralbone anchoring component 112 to have a porous structure that encourages bone in-growth. Accordingly, the femoralbone anchoring component 112 may be formed of a metal such as Titanium, or specifically, direct metal laser sintered (“DMLS”) Titanium. The femoralbone anchoring component 112 may be formed via an additive manufacturing method such as 3D printing. Such manufacturing methods may facilitate the creation of a porous structure, particularly on the bone-facingside 126 of the femoralbone anchoring component 112. - In some embodiments, the femoral
bone anchoring component 112 may be made such that the porosity varies in a gradient through the thickness of the femoralbone anchoring component 112. Thus, the bone-facingside 126 of the femoralbone anchoring component 112 may be made more porous to facilitate bone in-growth, while the joint-facingside 124 of the femoralbone anchoring component 112 may be made less porous to enhance attachment of the joint-facingside 124 to the bone-facingside 122 of the femoral articulatingcomponent 110. In some embodiments, the joint-facingside 124 may be made substantially solid (i.e., nonporous) to enhance adhesion to the bone-facingside 122 of the femoral articulatingcomponent 110, while the bone-facingside 126 may be highly porous. - As shown, the bone-facing
side 122 of the femoral articulatingcomponent 110 may have ananterior portion 200, aposterior portion 202, and adistal portion 204. Upon implantation of the femoral articulatingcomponent 110, theanterior portion 200 may be located on the anterior side of the knee, theposterior portion 202 may be located on the posterior side of the knee, and thedistal portion 204 may be located at the distal end of the femur. Thedistal portion 204 may be divided into three faces: an anterior-distal face 206, a posterior-distal face 208, and adistal face 210. The anterior-distal face 206 may reside between theanterior portion 200 and thedistal face 210, and the posterior-distal face 208 may be reside between theposterior portion 202 and thedistal face 210. As shown, theposts 150 may protrude from thedistal face 210. - The
posts 150 may all protrude in a cephalad direction so that these features can penetrate the bone, helping to anchor the femoral articulatingcomponent 110 on the distal end of the femur (not shown). Theposts 150 may optionally be shaped to facilitate entry into and/or compaction of the bone. Thus, the bone surrounding theposts 150 in their implanted state may be compacted and/or strengthened. - As also shown in
FIG. 2 , the bone-facingside 122 of the femoral articulatingcomponent 110 may have aperipheral ridge 220 that defines aninterior recess 222. The shape of theinterior recess 222 may closely match that of the joint-facingside 124 of the femoralbone anchoring component 112 so that the joint-facingside 124 of the femoralbone anchoring component 112 can be secured to theinterior recess 222. When the femoralbone anchoring component 112 and the femoral articulatingcomponent 110 are assembled together, the bone-facingside 126 of the femoralbone anchoring component 112 may lie substantially flush with theperipheral ridge 220 of the bone-facingside 122 of the femoral articulatingcomponent 110. - In some embodiments, the bone-facing
side 126 of the femoralbone anchoring component 112 may be treated to enhance porosity and/or bone in-growth. In some examples, the bone-facingside 126 of the femoralbone anchoring component 112 may be processed via a process such as anodizing to form Titanium Dioxide nanotubes on the bone-facingside 126. Specifically, the bone-facingside 126 may be anodized in a Fluoride electrolyte, as set forth in U.S. application Ser. No. 11/913,062, filed Jun. 10, 2008 and entitled “Compositions Comprising Nanostructures for Cell, Tissue and Artificial Organ Growth, and Methods for Making and Using Same, now U.S. Pat. No. 8,414,908, which is incorporated by reference as though set forth herein in its entirety. The result may be the formation of asurface layer 230 of Titanium Dioxide nanotubes on the bone-facingside 126. - The femoral articulating
component 110 and the femoralbone anchoring component 112 may be secured together in a variety of ways. One exemplary attachment method will be set forth as follows. Those of skill in the art will recognize that various steps set forth below may be omitted, replaced with alternative steps, and/or supplemented with additional steps not specifically provided herein. Further, the following steps are not limited to knee implants, but may be used in connection with any implant having an articulating component and a bone engagement component. - A
paste 240 may be made from nanoparticles of a metal such as commercially pure Titanium. The nanoparticles may be formed in a variety of ways. According to one embodiment, Titanium nanoparticles may be made by ball milling a Titanium halide such as Titanium Chloride, with a metal reactant such as Magnesium. However, other metals, such as those of group 1 and group 2, may be used for the reactant. The mechanical action and formation of salt byproduct may prevent particle growth and produce fine particles. The salt byproduct may be removed via solvation in water or an aprotic solvent with a high dielectric constant, such as formaldehyde. Further details may be found in Blair, R. G., E. G. Gillan, N. K. B. Nguyen, D. Daurio, and R. B. Kaner, Rapid solid-state synthesis of titanium aluminides. Chemistry of Materials, 2003. 15(17): p. 3286-3293, and in Restrepo, D., S. M. Hick, C. Griebel, J. Alarcon, K. Giesler, Y. Chen, N. Orlovskaya, and R. G. Blair, Size controlled mechanochemical synthesis of ZrSi 2. Chemical Communications, 2013. 49: p. 707-709. - The result may be formation of nanoparticles of Titanium. The nanoparticles may be less than 20 nm in cross-sectional size, and need not be spherical but may instead be flake-shaped. The nanoparticles may thus have a melting temperature much lower than that of bulk Titanium. In order to provide a consistently lowered melting temperature, it may be desirable to provide the nanoparticles in a fairly tight Gaussian distribution, for example, 15 nm average size, +/−5 nm. Even a few particles greater than 25 nm in size may cause the melting temperature to rise. The low melting temperature may help the nanoparticles to melt into the adjoining material (for example, CrCo and Ti) and mechanically bond therewith, rather than diffusion bonding, as will be discussed subsequently.
- The Titanium nanoparticles may be added to material such as a gelatin and/or glycerin to form the
paste 240. The paste may be applied to one or both of the surfaces to be secured together, which, for thefemoral prosthesis 102, may be the joint-facingside 124 of the femoralbone anchoring component 112 and theinterior recess 222 of the bone-facingside 122 of the femoral articulatingcomponent 110. Thepaste 240 depicted inFIG. 2 , on the joint-facingside 124 and theinterior recess 222 is merely exemplary; it may be advantageous to spread thepaste 240 over substantially the entire surface of the joint-facingside 124 or theinterior recess 222. - The
paste 240 may be applied in a variety of ways, such as spraying the surface to be coated, immersing the surface to be coated in a quantity of the paste, and/or spreading thepaste 240 on the surface with a brush or other implement. The use of the gelatin and/or glycerin may facilitate adhesion of thepaste 240 to the joint-facingside 124 and the bone-facingside 122. - The femoral articulating
component 110 and the femoralbone anchoring component 112 may then be assembled together such that the joint-facingside 124 of the femoralbone anchoring component 112 is in contact with the bone-facingside 122 of the femoral articulatingcomponent 110. The femoral articulatingcomponent 110 and the femoralbone anchoring component 112 may be compressed together. In some embodiments, this may be done by positioning thefemoral articulating component 110 above the femoralbone anchoring component 112, so that the weight of the femoral articulatingcomponent 110 urges the femoral articulatingcomponent 110 against the femoralbone anchoring component 112. Alternatively, a carbon fixture or other implement may be used to urge the femoral articulatingcomponent 110 and the femoralbone anchoring component 112 together. - The femoral articulating
component 110 and the femoralbone anchoring component 112 may then be placed into a vacuum furnace or other heating implement. If desired, thefemoral articulating component 110 and the femoralbone anchoring component 112 may continue to be compressed together as these parts are inserted into the furnace and heated. The furnace may then be used to heat thefemoral articulating component 110 and the femoralbone anchoring component 112. - As the temperature of the femoral articulating
component 110 and/or the femoralbone anchoring component 112 reaches about 200-300° C., the gelatin and/or glycerin may be burned away (debind process), and Carbon may be outgassed from the partial pressure vacuum furnace via an inert carrier gas. The Titanium nanoparticles may be left with air between their spheres. The furnace may be used to further heat thefemoral articulating component 110 and the femoralbone anchoring component 112 to a bonding temperature of about 500° C., at which the Titanium nanoparticles may begin to melt, securing the joint-facingside 124 of the femoralbone anchoring component 112 to the bone-facingside 122 of the femoral articulatingcomponent 110. The femoral articulatingcomponent 110 and the femoralbone anchoring component 112 may then be removed from the furnace and allowed to cool. - At the bonding temperature, the Titanium Dioxide nanotubes may turn into anatase. This may be advantageous because, when compared with amorphous Titanium Dioxide, anatase may have greater strength and superior bone bonding characteristics. Thus, the surface properties of the bone-facing
side 126 of the femoralbone anchoring component 112 may be enhanced by the process used to bond the femoralbone anchoring component 112 to the femoral articulatingcomponent 110. - Advantageously, the maximum temperature of this process may be the bonding temperature, which may be much lower than the melting temperatures of the significant constituent metals of which the
femoral articulating component 110 is formed. Specifically, the melting temperature of Cobalt is 1,995° C., the melting temperature of Chromium is 1,907° C., and the melting temperature of Molybdenum is 2,623° C. Thus, the bonding process used to secure the femoral articulatingcomponent 110 to the femoralbone anchoring component 112 may not change the crystalline structure of the femoralbone anchoring component 112, as determined by the manufacturing process (for example, casting) used to form the femoralbone anchoring component 112. Thus, formation of brittle alloys may be avoided, which may occur in known processes in which conventional Titanium is diffusion bonded to Cobalt Chromium Molybdenum. - In addition to or in the alternative to the use of Titanium nanoparticles, a variety of other metals may be used to bond the femoral articulating
component 110 to the femoralbone anchoring component 112. Nanoparticles of metals often have melting temperatures lower than those of the corresponding bulk metals; accordingly, a wide variety of nanoparticles, including Titanium, Cobalt, and Chromium nanoparticles, may be used. Additionally or alternatively, metals with lower melting temperatures than Titanium, Cobalt, and Chromium may be used in bulk, rather than nanoparticle, form. For example, Nitinol has a melting temperature of about 1400° C., which is also lower than the melting temperatures of Titanium, Cobalt, and Chromium. Thus, thepaste 240, in some embodiments may include a Nitinol powder, which need not be in the form of nanoparticles. - The bond formed between the joint-facing
side 124 of the femoralbone anchoring component 112 and the bone-facingside 122 of the femoral articulatingcomponent 110 may be a physical bond rather than a metallurgical bond. Thus, the Titanium nanoparticles may flow into surface irregularities in the joint-facingside 124 of the femoralbone anchoring component 112 and/or the bone-facingside 122 of the femoral articulatingcomponent 110 so that, when the Titanium nanoparticles re-freeze, they secure the femoral articulatingcomponent 110 and the femoralbone anchoring component 112 together. Avoidance of a metallurgical bond is advantageous in that such bonds can disrupt the crystalline structure of the materials being bonded. Thus, the low bonding temperature of the method set forth herein has many advantages, and may provide thefemoral prosthesis 102 with enhanced wear resistance and/or bone adhesion. - A second attachment method may be used in addition to or in the alternative to the foregoing. The femoral
bone anchoring component 112 may be placed in theinterior recess 222 of the bone-facingside 122 of the femoral articulatingcomponent 110. A laser may be used to melt the metal of both components together along the perimeter and/or along the seams between the femoralbone anchoring component 112 and the femoral articulatingcomponent 110. - A third attachment method may be used in addition to or in the alternative to either or both of the foregoing. A metallic powder and binder mixture may be placed along the perimeter and/or the seams of the femoral
bone anchoring component 112 prior to placement of the femoralbone anchoring component 112 in theinterior recess 222 of the bone-facingside 122 of the femoral articulatingcomponent 110. A laser may be used to melt the metal powder and binder mixture along the perimeter and/or the seams. The re-solidified metal may bond the femoralbone anchoring component 112 and the femoral articulatingcomponent 110 together. - In addition to or in the alternative to the foregoing attachment methods, the methods disclosed in U.S. application Ser. No. 10/455,846, filed Jun. 6, 2003 and entitled “METHOD FOR ATTACHING A POROUS METAL LAYER TO A METAL SUBSTRATE,” now U.S. Pat. No. 6,945,448, may be used. This application is incorporated as though set forth herein in its entirety.
- The same method (or a similar method) may be used to secure the
tibial articulating component 114 to the tibialbone anchoring component 116. Further, as mentioned previously, such bonding methods may be used not just for knee implants, but for other types of implants, and in particular, orthopedic implants in which an articulating component is to be secured to a bone anchoring component. - The method set forth above may be effective for relatively smooth surfaces. However, if desired, the surfaces to be bonded together may have features that facilitate and/or enhance the results of the bonding process. For example, the bone-facing
side 122 of the femoral articulatingcomponent 110 may have features that cooperate with corresponding features (shown inFIG. 4 ) on the joint-facingside 124 of the femoralbone anchoring component 112 to help align the femoral articulatingcomponent 110 with the femoralbone anchoring component 112 and/or add mechanical fastening to the bonding described above. These features of the bone-facingside 122 may include, by way of example, a pair ofpost bosses 250. -
FIG. 3 is an exploded, perspective view, from a different viewpoint, of thefemoral prosthesis 102 of thesystem 100 ofFIG. 1 . The joint-facingside 124 of the femoralbone anchoring component 112 and the joint-facingside 120 of the femoral articulatingcomponent 110 are more clearly visible. - As shown, the joint-facing
side 124 of the femoralbone anchoring component 112 may have features that cooperate with thepost bosses 250 of the bone-facingside 122 of the femoral articulatingcomponent 110 depicted inFIG. 2 . These features may include, for example, post bores 350. Each of the post bores 350 may reside in the interior of one of theposts 150. The post bores 350 may be shaped to receive thepost bosses 250. If desired, thepost bosses 250 may each be tapered to facilitate insertion into the post bores 350. - The features of the bone-facing
side 122 may be received by these features of the joint-facingside 124 with some interference, which may cooperate with the bond described above to enhance attachment of the bone-facingside 122 to the joint-facingside 124. When the femoral articulatingcomponent 110 and the femoralbone anchoring component 112 are compressed together, as set forth above, the compression may be sufficient to urge thepost bosses 250 into the post bores 350. - Additionally or alternatively, the heat applied to the femoral articulating
component 110 and the femoralbone anchoring component 112 may cause thermal expansion eases insertion of thepost bosses 250 into the post bores 350. The femoral articulatingcomponent 110 may be made such that the femoral articulatingcomponent 110 has higher thermal expansion than the femoralbone anchoring component 112. Thus, after insertion of the bosses into the bores, thefemoral articulating component 110 and the femoralbone anchoring component 112 may be cooled, allowing the bores to tighten around the bosses. - In alternative embodiments, other positive and/or negative features may be used. Further, if desired, the positive features may be on the joint-facing
side 124 of the femoralbone anchoring component 112, and the negative features may be on the bone-facingside 122 of the femoral articulatingcomponent 110. -
FIG. 4 is an exploded, perspective view of thetibial prosthesis 104 of thesystem 100 ofFIG. 1 . As with thefemoral prosthesis 102, thetibial articulating component 114 and the tibialbone anchoring component 116 may optionally be manufactured separately from each other. Accordingly, different manufacturing processes may be used to form thetibial articulating component 114 and the tibialbone anchoring component 116. For example, thetibial articulating component 114 may be formed via casting, and the tibialbone anchoring component 116 may be formed via additive manufacturing such as 3D printing. - Like the femoral articulating
component 110, thetibial articulating component 114 may be made of Cobalt Chromium, or Cobalt Chromium Molybdenum. Similarly, like the femoralbone anchoring component 112, the tibialbone anchoring component 116 may be made of DMLS Titanium. A gradient of porosities may be present in the tibialbone anchoring component 116, with greater porosity on the bone-facingside 136, and lesser porosity on the joint-facingside 134. If desired, the joint-facingside 134 may be made substantially nonporous to enhance adhesion to thetibial articulating component 114, and the bone-facingside 136 may have a high level of porosity to promote bone in-growth. - As shown, the bone-facing
side 132 of thetibial articulating component 114 may have acentral plateau 400 that extends toward the tibialbone anchoring component 116, and aperipheral recess 402 that encircles thecentral plateau 400 and is recessed from the tibialbone anchoring component 116. The joint-facingside 134 of the tibialbone anchoring component 116 may have a shape that is complementary to that of the bone-facingside 132 of thetibial articulating component 114. Specifically, the joint-facingside 134 may have aperipheral ridge 410 that encircles aninterior recess 412. Analcove 414 may extend into theperipheral ridge 410, from the space above theinterior recess 412. When the tibial articulatingcomponent 114 and the tibialbone anchoring component 116 are assembled together, thecentral plateau 400 may be received within theinterior recess 412, and theperipheral ridge 410 may engage thecentral plateau 400. - In some embodiments, the
tibial articulating component 114 and the tibialbone anchoring component 116 may be secured together by the same bonding process described above in connection with the femoral articulatingcomponent 110 and the femoralbone anchoring component 112 of thefemoral prosthesis 102, or with a modified version of such a bonding process. Thus,FIG. 4 depicts the exemplary application of thepaste 240 to theinterior recess 412 of the joint-facingside 134 of the tibialbone anchoring component 116. -
FIG. 5 is an exploded, perspective view, from a different viewpoint, of thetibial prosthesis 104 of thesystem 100 ofFIG. 1 . As shown, thecentral plateau 400 of the bone-facingside 132 of thetibial articulating component 114 may have alip 500 that protrudes anteriorly. When the tibial articulatingcomponent 114 and the tibialbone anchoring component 116 are assembled, thelip 500 may protrude into thealcove 414 depicted inFIG. 4 . Engagement of thelip 500 and thealcove 414 may further help to hold the anterior portions of thetibial articulating component 114 and the tibialbone anchoring component 116 together. -
FIG. 5 also depicts the bone-facingside 136 of the tibialbone anchoring component 116 in greater detail. Four of theposts 190 may be present on the bone-facingside 136, and may help enhance the level of engagement of the bone-facingside 136 with the underlying bone, and in particular, with the cortical bone at the proximal end of the tibia. Theposts 190 may also increase the surface area of the bone-facingside 136 in contact with the bone of the tibia, thereby further enhancing the potential for bone cement bonding and/or bone in-growth between the tibia and the bone-facingside 136. - Further, if desired, the tibial
bone anchoring component 116 may be processed as described above in the description of the femoralbone anchoring component 112, such that the tibialbone anchoring component 116 has asurface layer 230 formed of Titanium Dioxide nanotubes. Such asurface layer 230 may further enhance bone in-growth to further secure the bone-facingside 136 to the bone of the tibia. - As mentioned previously, the
tibial articulating component 114 and the tibialbone anchoring component 116 may be secured together through the use of a method like that set forth in the description of the femoral articulatingcomponent 110 and the femoralbone anchoring component 112. In the course of such a method, thepaste 240 may be applied to the bone-facingside 132 of thetibial articulating component 114 and/or to the joint-facingside 134 of the tibialbone anchoring component 116. - Any methods disclosed herein comprise one or more steps or actions for performing the described method. The method steps and/or actions may be interchanged with one another. In other words, unless a specific order of steps or actions is required for proper operation of the embodiment, the order and/or use of specific steps and/or actions may be modified.
- Reference throughout this specification to “an embodiment” or “the embodiment” means that a particular feature, structure or characteristic described in connection with that embodiment is included in at least one embodiment. Thus, the quoted phrases, or variations thereof, as recited throughout this specification are not necessarily all referring to the same embodiment.
- Similarly, it should be appreciated that in the above description of embodiments, various features are sometimes grouped together in a single embodiment, Figure, or description thereof for the purpose of streamlining the disclosure. This method of disclosure, however, is not to be interpreted as reflecting an intention that any claim require more features than those expressly recited in that claim. Rather, as the following claims reflect, inventive aspects lie in a combination of fewer than all features of any single foregoing disclosed embodiment. Thus, the claims following this Detailed Description are hereby expressly incorporated into this Detailed Description, with each claim standing on its own as a separate embodiment. This disclosure includes all permutations of the independent claims with their dependent claims.
- Recitation in the claims of the term “first” with respect to a feature or element does not necessarily imply the existence of a second or additional such feature or element. Elements recited in means-plus-function format are intended to be construed in accordance with 35 U.S.C. § 112 Para. 6. It will be apparent to those having skill in the art that changes may be made to the details of the above-described embodiments without departing from the underlying principles set forth herein.
- While specific embodiments and applications of the present disclosure have been illustrated and described, it is to be understood that the scope of the appended claims is not limited to the precise configuration and components disclosed herein. Various modifications, changes, and variations which will be apparent to those skilled in the art may be made in the arrangement, operation, and details of the methods and systems disclosed herein.
Claims (20)
1. A prosthesis for replacing an articular surface on bone, the prosthesis comprising:
an articulating component formed via casting, the articulating component comprising:
an articulating component joint-facing side comprising an articular surface; and
an articulating component bone-facing side comprising a bone-facing shape; and
a bone anchoring component having a 3D printed structure, the bone anchoring component comprising:
a bone anchoring component joint-facing side comprising a joint-facing shape that is complementary to the bone-facing shape, wherein the bone anchoring component joint-facing side is secured to the articulating component bone-facing side; and
a bone anchoring component bone-facing side comprising a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores.
2. The prosthesis of claim 1 , wherein:
the bone anchoring component is formed of DMLS Titanium; and
the 3D printed structure comprises a porous structure.
3. The prosthesis of claim 2 , wherein the porous structure has a lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side.
4. The prosthesis of claim 1 , wherein the bone anchoring component joint-facing side comprises a surface layer of Titanium Dioxide nanotubes formed via anodization.
5. The prosthesis of claim 4 , wherein the Titanium Dioxide nanotubes comprise an anatase structure.
6. The prosthesis of claim 1 , wherein:
the articulating component is formed of an alloy of Cobalt Chromium comprising one or more crystalline structures established by a casting process used to form the articulating component; and
the bone anchoring component joint-facing side is secured to the articulating component bone-facing side via a bonding process occurring at a bonding temperature far below melting temperatures of Cobalt and Chromium, such the crystalline structures are not significantly modified by the bonding process.
7. The prosthesis of claim 6 , wherein:
the bonding process occurs at a bonding temperature, at the bone anchoring component joint-facing side and the articulating component bone-facing side, of about 500° C.; and
the prosthesis further comprises a bonding zone, between the bone anchoring component joint-facing side and the articulating component bone-facing side, formed of melted and re-solidified Titanium nanoparticles.
8. The prosthesis of claim 6 , wherein:
the bonding process occurs via laser welding a perimeter and/or seams of the bone anchoring component joint-facing side and the articulating component bone-facing side together; and
the prosthesis further comprises a bonding zone at the perimeter and/or seams, formed of melted and re-solidified Titanium, Cobalt, and/or Chromium nanoparticles.
9. A method for manufacturing a prosthesis for replacing an articular surface on a bone, the method comprising:
casting an articulating component comprising:
an articulating component joint-facing side comprising an articular surface; and
an articulating component bone-facing side comprising a bone-facing shape; and
3D printing a bone anchoring component comprising:
a bone anchoring component joint-facing side comprising a joint-facing shape that is complementary to the bone-facing shape; and
a bone anchoring component bone-facing side comprising a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores; and
securing the bone anchoring component joint-facing side to the articulating component bone-facing side.
10. The method of claim 9 , wherein 3D printing the bone anchoring component comprises direct metal laser sintering Titanium to form a porous structure.
11. The method of claim 9 , wherein forming the porous structure comprises providing lower porosity on the bone anchoring component joint-facing side than on the bone anchoring component bone-facing side.
12. The method of claim 9 , further comprising anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side.
13. The method of claim 12 , further comprising heating the bone anchoring component to a temperature sufficient to change at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
14. The method of claim 9 , wherein:
casting articulating component comprises casting the articulating component from an alloy of Cobalt Chromium to establish one or more crystalline structures of the alloy of Cobalt Chromium; and
securing the bone anchoring component joint-facing side to the articulating component bone-facing side comprises heating at least part of the bone anchoring component and at least part of the articulating component to a bonding temperature far below melting temperatures of Cobalt and Chromium, so as to avoid significantly modifying the crystalline structures.
15. The method of claim 14 , wherein heating at least part of the bone anchoring component and part of the articulating component to the bonding temperature comprises laser welding a perimeter and/or seams of the bone anchoring component joint-facing side and the articulating component bone-facing side together.
16. The method of claim 14 , further comprising, prior to heating at least part of the bone anchoring component and part of the articulating component to the bonding temperature, applying a paste to one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side, the paste comprising Titanium nanoparticles and a gelatin and/or a glycerin.
17. The method of claim 16 , further comprising, after applying the paste on one or both of the bone anchoring component joint-facing side and the articulating component bone-facing side, and prior to heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature:
assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side; and
pressing the bone anchoring component joint-facing side and the articulating component bone-facing side together.
18. The method of claim 17 , wherein heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to the bonding temperature comprises, with the bone anchoring component joint-facing side and the articulating component bone-facing side pressed together, heating at least the bone anchoring component joint-facing side and the articulating component bone-facing side to about 500° C. to debind the gelatin and/or glycerin and melt the Titanium nanoparticles.
19. A method for manufacturing a prosthesis for replacing an articular surface on a bone, the method comprising:
casting metals comprising at least Cobalt and Chromium to form an articulating component comprising:
an articulating component joint-facing side comprising an articular surface; and
an articulating component bone-facing side comprising a bone-facing shape; and
direct metal laser sintering Titanium to form a bone anchoring component comprising:
a bone anchoring component joint-facing side comprising a joint-facing shape that is complementary to the bone-facing shape; and
a bone anchoring component bone-facing side comprising a bone engagement surface having a porous structure with pores selected to facilitate in-growth of the bone into the pores;
applying a paste containing Titanium nanoparticles to at least one of the bone anchoring component joint-facing side and the articulating component bone-facing side;
assembling the articulating component and the bone anchoring component such that the paste is sandwiched between the bone anchoring component joint-facing side and the articulating component bone-facing side; and
heating the paste to a bonding temperature sufficient to commence melting of the Titanium nanoparticles to secure the bone anchoring component joint-facing side to the articulating component bone-facing side.
20. The method of claim 19 , further comprising:
anodizing the bone anchoring component to form a surface layer of Titanium Dioxide nanotubes on the bone anchoring component joint-facing side; and
after assembling the articulating component and the bone anchoring component, pressing the articulating component and the bone anchoring component together;
wherein:
the paste further comprises a gelatin and/or a glycerin; and
heating the paste to the bonding temperature comprises, with the articulating component and the bone anchoring component pressed together, heating at least the bone anchoring component joint-facing side and the articulating component to about 500° C. to debind the gelatin and/or glycerin, melt the Titanium nanoparticles, and changing at least a portion of the surface layer of Titanium Dioxide nanotubes to anatase.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US16/660,964 US20200054346A1 (en) | 2017-03-02 | 2019-10-23 | Composite joint arthroplasty systems and methods |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201762466249P | 2017-03-02 | 2017-03-02 | |
US15/625,802 US10456143B2 (en) | 2017-03-02 | 2017-06-16 | Composite joint arthroplasty systems and methods |
US16/660,964 US20200054346A1 (en) | 2017-03-02 | 2019-10-23 | Composite joint arthroplasty systems and methods |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/625,802 Continuation US10456143B2 (en) | 2017-03-02 | 2017-06-16 | Composite joint arthroplasty systems and methods |
Publications (1)
Publication Number | Publication Date |
---|---|
US20200054346A1 true US20200054346A1 (en) | 2020-02-20 |
Family
ID=63357095
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/622,688 Active 2038-12-11 US10905436B2 (en) | 2017-03-02 | 2017-06-14 | Knee arthroplasty systems and methods |
US15/624,488 Active 2038-05-09 US10512471B2 (en) | 2017-03-02 | 2017-06-15 | Knee arthroplasty systems and methods |
US15/625,802 Active 2037-07-24 US10456143B2 (en) | 2017-03-02 | 2017-06-16 | Composite joint arthroplasty systems and methods |
US16/660,964 Abandoned US20200054346A1 (en) | 2017-03-02 | 2019-10-23 | Composite joint arthroplasty systems and methods |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/622,688 Active 2038-12-11 US10905436B2 (en) | 2017-03-02 | 2017-06-14 | Knee arthroplasty systems and methods |
US15/624,488 Active 2038-05-09 US10512471B2 (en) | 2017-03-02 | 2017-06-15 | Knee arthroplasty systems and methods |
US15/625,802 Active 2037-07-24 US10456143B2 (en) | 2017-03-02 | 2017-06-16 | Composite joint arthroplasty systems and methods |
Country Status (3)
Country | Link |
---|---|
US (4) | US10905436B2 (en) |
EP (1) | EP3589239A1 (en) |
WO (2) | WO2018160481A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11730603B2 (en) | 2020-09-03 | 2023-08-22 | Globus Medical, Inc. | Systems and methods for knee arthroplasty |
US11844697B2 (en) | 2020-09-03 | 2023-12-19 | Globus Medical, Inc. | Systems and methods for knee arthroplasty |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10182917B2 (en) * | 2016-04-11 | 2019-01-22 | Arthrex, Inc. | Components for artificial joints |
US10905436B2 (en) * | 2017-03-02 | 2021-02-02 | Optimotion Implants, Llc | Knee arthroplasty systems and methods |
US11406502B2 (en) | 2017-03-02 | 2022-08-09 | Optimotion Implants LLC | Orthopedic implants and methods |
US12083027B2 (en) | 2017-03-02 | 2024-09-10 | Optimotion Implants LLC | Universal femoral trial system and methods |
CN111085683B (en) * | 2019-12-11 | 2021-08-20 | 贵州航宇科技发展股份有限公司 | Manufacturing method of annular special-shaped component |
CN112315627B (en) * | 2020-10-30 | 2024-04-09 | 嘉思特医疗器材(天津)股份有限公司 | Zirconia-niobium alloy tibial plateau prosthesis with bone trabecula and preparation method thereof |
CN112294499B (en) * | 2020-10-30 | 2024-04-09 | 嘉思特医疗器材(天津)股份有限公司 | Oxide layer-containing zirconium-niobium alloy zoned bone small Liang Gugu condyle prosthesis and preparation method thereof |
US20220265288A1 (en) * | 2021-02-24 | 2022-08-25 | Wright Medical Technology, Inc. | Cut guide, systems, and methods |
US11903845B2 (en) * | 2022-02-25 | 2024-02-20 | Globus Medical Inc. | Tibial tray inserter |
US20240207053A1 (en) * | 2022-12-22 | 2024-06-27 | Howmedica Osteonics Corp. | Fixtures for Masking Metal Parts |
Family Cites Families (135)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4659331A (en) * | 1983-11-28 | 1987-04-21 | Regents Of University Of Michigan | Prosthesis interface surface and method of implanting |
US4950298A (en) * | 1988-04-08 | 1990-08-21 | Gustilo Ramon B | Modular knee joint prosthesis |
US5116375A (en) * | 1990-08-27 | 1992-05-26 | Hofmann Aaron A | Knee prosthesis |
US5271737A (en) | 1992-09-04 | 1993-12-21 | U.S. Medical Products, Inc. | Tibial prosthetic implant with offset stem |
FR2702368B1 (en) | 1993-03-10 | 1995-06-09 | Medinov Sa | Tibial implant for knee prosthesis. |
CA2142636C (en) | 1994-02-18 | 2005-09-20 | Salvatore Caldarise | Implantable articles with as-cast macrotextured surface regions and method of manufacturing the same |
US5504300A (en) * | 1994-04-18 | 1996-04-02 | Zimmer, Inc. | Orthopaedic implant and method of making same |
US6105235A (en) | 1994-04-28 | 2000-08-22 | Johnson & Johnson Professional, Inc. | Ceramic/metallic articulation component and prosthesis |
US5980974A (en) | 1996-01-19 | 1999-11-09 | Implant Sciences Corporation | Coated orthopaedic implant components |
US5653714A (en) | 1996-02-22 | 1997-08-05 | Zimmer, Inc. | Dual slide cutting guide |
US6087553A (en) | 1996-02-26 | 2000-07-11 | Implex Corporation | Implantable metallic open-celled lattice/polyethylene composite material and devices |
US6258127B1 (en) | 1996-09-11 | 2001-07-10 | Plus Endoprothetik Ag | Tibia part of a new joint endoprosthesis |
US5716412A (en) | 1996-09-30 | 1998-02-10 | Johnson & Johnson Professional, Inc. | Implantable article with ablated surface |
US5762125A (en) | 1996-09-30 | 1998-06-09 | Johnson & Johnson Professional, Inc. | Custom bioimplantable article |
US5824100A (en) | 1996-10-30 | 1998-10-20 | Osteonics Corp. | Knee prosthesis with increased balance and reduced bearing stress |
DE19647155C2 (en) * | 1996-11-14 | 1998-11-19 | Plus Endoprothetik Ag | Implant |
US8480754B2 (en) | 2001-05-25 | 2013-07-09 | Conformis, Inc. | Patient-adapted and improved articular implants, designs and related guide tools |
US8882847B2 (en) * | 2001-05-25 | 2014-11-11 | Conformis, Inc. | Patient selectable knee joint arthroplasty devices |
US8735773B2 (en) | 2007-02-14 | 2014-05-27 | Conformis, Inc. | Implant device and method for manufacture |
US5824103A (en) | 1997-05-12 | 1998-10-20 | Howmedica Inc. | Tibial prosthesis |
EP0956836B1 (en) | 1998-05-13 | 2004-07-28 | DePuy Products, Inc. | Tibial tray with adjustable keel |
US6261322B1 (en) | 1998-05-14 | 2001-07-17 | Hayes Medical, Inc. | Implant with composite coating |
US7635390B1 (en) | 2000-01-14 | 2009-12-22 | Marctec, Llc | Joint replacement component having a modular articulating surface |
DE60111253T2 (en) | 2000-07-20 | 2006-04-20 | Hayes Medical, Inc., El Dorado Hills | RAIL INSERT FROM A BIMETAL FOR APPLICATION IN A KNEE PROSTHESIS |
US7018418B2 (en) | 2001-01-25 | 2006-03-28 | Tecomet, Inc. | Textured surface having undercut micro recesses in a surface |
US7497874B1 (en) | 2001-02-23 | 2009-03-03 | Biomet Manufacturing Corp. | Knee joint prosthesis |
US7087200B2 (en) | 2001-06-22 | 2006-08-08 | The Regents Of The University Of Michigan | Controlled local/global and micro/macro-porous 3D plastic, polymer and ceramic/cement composite scaffold fabrication and applications thereof |
US6858032B2 (en) | 2001-08-23 | 2005-02-22 | Midwest Orthopaedic Research Foundation | Rotating track cutting guide system |
HUP0500442A2 (en) | 2001-12-06 | 2005-08-29 | Smith & Nephew, Inc. | In-situ oxidized textured surfaces for prosthetic devices and method of making same |
CA2475078C (en) | 2002-02-20 | 2010-05-04 | Thomas M. Coon | Knee arthroplasty prosthesis and method |
US7182786B2 (en) | 2002-04-25 | 2007-02-27 | Zimmer Technology, Inc. | Modular bone implant, tool, and method |
US7799086B2 (en) | 2002-04-25 | 2010-09-21 | Zimmer Technology, Inc. | Modular bone implant, tools, and method |
GB2388034B (en) | 2002-05-03 | 2005-01-12 | Corin Ltd | Fixing devices for prosthetic devices |
US7048741B2 (en) * | 2002-05-10 | 2006-05-23 | Swanson Todd V | Method and apparatus for minimally invasive knee arthroplasty |
US7918382B2 (en) | 2002-06-18 | 2011-04-05 | Zimmer Technology, Inc. | Method for attaching a porous metal layer to a metal substrate |
US6945448B2 (en) | 2002-06-18 | 2005-09-20 | Zimmer Technology, Inc. | Method for attaching a porous metal layer to a metal substrate |
US20060147332A1 (en) | 2004-12-30 | 2006-07-06 | Howmedica Osteonics Corp. | Laser-produced porous structure |
EP1418013B1 (en) | 2002-11-08 | 2005-01-19 | Howmedica Osteonics Corp. | Laser-produced porous surface |
CA2416348C (en) | 2003-01-14 | 2009-09-01 | Michael Lococo | Bone implant and device for forming a socket for same |
US7837690B2 (en) | 2003-01-15 | 2010-11-23 | Biomet Manufacturing Corp. | Method and apparatus for less invasive knee resection |
US7887542B2 (en) | 2003-01-15 | 2011-02-15 | Biomet Manufacturing Corp. | Method and apparatus for less invasive knee resection |
US8551100B2 (en) | 2003-01-15 | 2013-10-08 | Biomet Manufacturing, Llc | Instrumentation for knee resection |
US7160330B2 (en) | 2003-01-21 | 2007-01-09 | Howmedica Osteonics Corp. | Emulating natural knee kinematics in a knee prosthesis |
US7309339B2 (en) | 2003-02-04 | 2007-12-18 | Howmedica Osteonics Corp. | Apparatus for aligning an instrument during a surgical procedure |
US7081137B1 (en) | 2003-06-23 | 2006-07-25 | Howmedica Osteonics Corp. | Knee prosthesis with extended range of motion |
US7001672B2 (en) | 2003-12-03 | 2006-02-21 | Medicine Lodge, Inc. | Laser based metal deposition of implant structures |
US7666522B2 (en) | 2003-12-03 | 2010-02-23 | IMDS, Inc. | Laser based metal deposition (LBMD) of implant structures |
US7294149B2 (en) | 2003-12-05 | 2007-11-13 | Howmedica Osteonics Corp. | Orthopedic implant with angled pegs |
US6974625B2 (en) | 2003-12-16 | 2005-12-13 | Smith & Nephew, Inc. | Oxidized zirconium on a porous structure for bone implant use |
US7679595B2 (en) * | 2004-07-30 | 2010-03-16 | Tpo Displays Corp. | Image sticking prevention circuit for display device |
US7524334B2 (en) | 2004-11-29 | 2009-04-28 | Haidukewych George J | Tibial tray for total knee arthroplasty |
US20060229715A1 (en) * | 2005-03-29 | 2006-10-12 | Sdgi Holdings, Inc. | Implants incorporating nanotubes and methods for producing the same |
US8414908B2 (en) | 2005-04-28 | 2013-04-09 | The Regents Of The University Of California | Compositions comprising nanostructures for cell, tissue and artificial organ growth, and methods for making and using same |
US7357817B2 (en) | 2005-05-19 | 2008-04-15 | Howmedica Osteonics Corp. | Modular keel tibial component |
US7413577B1 (en) | 2005-09-22 | 2008-08-19 | Howmedica Osteonics Corp. | Total stabilized knee prosthesis with constraint |
US8728387B2 (en) | 2005-12-06 | 2014-05-20 | Howmedica Osteonics Corp. | Laser-produced porous surface |
US7578851B2 (en) | 2005-12-23 | 2009-08-25 | Howmedica Osteonics Corp. | Gradient porous implant |
US8070821B2 (en) | 2005-12-27 | 2011-12-06 | Howmedica Osteonics Corp. | Hybrid femoral implant |
CA2572095C (en) | 2005-12-30 | 2009-12-08 | Howmedica Osteonics Corp. | Laser-produced implants |
US7625407B2 (en) | 2006-02-07 | 2009-12-01 | Howmedica Osteonics Corp. | Tibial prosthesis with asymmetric articular surfaces |
US7771484B2 (en) | 2006-02-28 | 2010-08-10 | Howmedica Osteonics Corp. | Modular tibial implant |
US8147861B2 (en) | 2006-08-15 | 2012-04-03 | Howmedica Osteonics Corp. | Antimicrobial implant |
US7938833B2 (en) | 2006-11-14 | 2011-05-10 | Howmedica Osteonics Corp. | Adjustable resection guide |
US7628817B1 (en) | 2006-12-14 | 2009-12-08 | Howmedica Osteonics Corp. | Soft tissue deflection at a prosthetic joint |
US9168155B2 (en) * | 2007-03-01 | 2015-10-27 | Zimmer, Inc. | Modular femoral provisional |
JP5725538B2 (en) | 2007-04-20 | 2015-05-27 | ウッドウェルディング・アクチェンゲゼルシャフト | Implant system and kit including the implant system |
US8133553B2 (en) | 2007-06-18 | 2012-03-13 | Zimmer, Inc. | Process for forming a ceramic layer |
WO2009014718A1 (en) | 2007-07-24 | 2009-01-29 | Porex Corporation | Porous laser sintered articles |
US8790345B2 (en) | 2007-08-21 | 2014-07-29 | Zimmer, Inc. | Titanium alloy with oxidized zirconium for a prosthetic implant |
US10213826B2 (en) | 2007-08-27 | 2019-02-26 | Connor E Samuelson | Systems and methods for providing prosthetic components |
US8632600B2 (en) | 2007-09-25 | 2014-01-21 | Depuy (Ireland) | Prosthesis with modular extensions |
US8715359B2 (en) | 2009-10-30 | 2014-05-06 | Depuy (Ireland) | Prosthesis for cemented fixation and method for making the prosthesis |
US20110230973A1 (en) * | 2007-10-10 | 2011-09-22 | Zimmer, Inc. | Method for bonding a tantalum structure to a cobalt-alloy substrate |
US8317869B2 (en) | 2008-02-06 | 2012-11-27 | Exactech, Inc. | Femoral component of knee prosthesis, the femoral component having anterior/posterior claw(s) for digging into bone and/or a raised rib with a bulbous terminus |
US8162949B2 (en) | 2008-04-21 | 2012-04-24 | Biomet Manufacturing Corp. | Tibial resection guide |
WO2010009242A2 (en) | 2008-07-16 | 2010-01-21 | Zimmer, Inc. | Thermally treated ceramic coating for implants |
US8529631B2 (en) | 2008-07-18 | 2013-09-10 | Zimmer, Gmbh | Base component for a tibial implant |
US9399086B2 (en) | 2009-07-24 | 2016-07-26 | Warsaw Orthopedic, Inc | Implantable medical devices |
EP3498228B1 (en) | 2009-08-19 | 2024-02-21 | Smith & Nephew, Inc | Porous implant structures |
US8383033B2 (en) | 2009-10-08 | 2013-02-26 | Biomet Manufacturing Corp. | Method of bonding porous metal to metal substrates |
US9445902B2 (en) | 2009-11-03 | 2016-09-20 | Howmedica Osteonics Corp. | Platform for soft tissue attachment |
US9480511B2 (en) | 2009-12-17 | 2016-11-01 | Engage Medical Holdings, Llc | Blade fixation for ankle fusion and arthroplasty |
CN101732761B (en) | 2010-01-01 | 2013-04-03 | 东南大学 | Joint prosthesis by using titanium oxide nanotubes to load bone morphogenetic protein |
ES2695400T3 (en) | 2010-01-29 | 2019-01-04 | Smith & Nephew Inc | Cross-retained knee prosthesis |
FR2957518B1 (en) * | 2010-03-16 | 2015-01-30 | Implanet | KNEE PROSTHESIS WITH MIXED MENISCALE PLAQUE |
US8388887B2 (en) | 2010-04-12 | 2013-03-05 | Biomet Manufacturing Corp. | Methods for making textured ceramic implants |
GB2480846B (en) | 2010-06-03 | 2017-04-19 | Biomet Uk Healthcare Ltd | Guiding tool |
US8545571B2 (en) | 2010-07-30 | 2013-10-01 | Howmedica Osteonics Corp. | Stabilized knee prosthesis |
WO2012021779A2 (en) | 2010-08-13 | 2012-02-16 | Smith & Nephew, Inc | Instruments for knee placement |
WO2012021764A2 (en) | 2010-08-13 | 2012-02-16 | Smith & Nephew, Inc. | Orthopaedic implants and methods |
EP2465549A1 (en) | 2010-11-17 | 2012-06-20 | Zimmer GmbH | Porous metal structures made from polymer preforms |
US9925051B2 (en) | 2010-12-16 | 2018-03-27 | Engage Medical Holdings, Llc | Arthroplasty systems and methods |
ES2552777T3 (en) | 2011-02-14 | 2015-12-02 | Hyun Bae, M.D. | System and method to remove a bone anchor |
EP3656355A1 (en) | 2011-05-06 | 2020-05-27 | Zimmer, Inc. | Patient-specific manufacturing of porous metal prostheses |
WO2012158604A1 (en) | 2011-05-13 | 2012-11-22 | Biomet Manufacturing Corp. | Bi-cruciate knee system |
EP2712308B1 (en) | 2011-05-20 | 2016-01-13 | Zimmer, Inc. | Stabilizing prosthesis support structure |
EP2901968B1 (en) | 2011-06-23 | 2020-02-12 | Stryker Corporation | Prosthetic implant |
US9254130B2 (en) | 2011-11-01 | 2016-02-09 | Hyun Bae | Blade anchor systems for bone fusion |
JP5824163B2 (en) | 2011-11-21 | 2015-11-25 | ジンマー,インコーポレイティド | Tibial bed plate with asymmetric mounting of fixed structure |
ES2508518T3 (en) | 2011-11-23 | 2014-10-16 | Waldemar Link Gmbh & Co. Kg | Device for forecasting a cutting plane for bone resection |
US9649195B2 (en) | 2011-12-29 | 2017-05-16 | Mako Surgical Corp. | Femoral implant for preserving cruciate ligaments |
US8911501B2 (en) | 2011-12-29 | 2014-12-16 | Mako Surgical Corp. | Cruciate-retaining tibial prosthesis |
US9668871B2 (en) | 2011-12-29 | 2017-06-06 | Mako Surgical Corp. | Cruciate-retaining tibial prosthesis |
AU2013210041B2 (en) | 2012-01-18 | 2017-10-05 | Smith & Nephew, Inc. | Compliant anti-resorption implant |
US9237950B2 (en) | 2012-02-02 | 2016-01-19 | Biomet Manufacturing, Llc | Implant with patient-specific porous structure |
US9155819B2 (en) | 2012-02-09 | 2015-10-13 | Mx Orthopedics, Corp. | Dynamic porous coating for orthopedic implant |
CA2870017A1 (en) | 2012-04-13 | 2013-10-17 | Conformis, Inc. | Devices and methods for additive manufacturing of implant components |
US20140010951A1 (en) | 2012-06-26 | 2014-01-09 | Zimmer, Inc. | Porous metal implants made from custom manufactured substrates |
US8843229B2 (en) | 2012-07-20 | 2014-09-23 | Biomet Manufacturing, Llc | Metallic structures having porous regions from imaged bone at pre-defined anatomic locations |
US9636229B2 (en) | 2012-09-20 | 2017-05-02 | Conformis, Inc. | Solid freeform fabrication of implant components |
US9265613B2 (en) | 2012-09-24 | 2016-02-23 | Russell Nevins | Cementless tibial implant |
US9370605B2 (en) | 2013-03-04 | 2016-06-21 | Howmedica Osteonics Corp. | Cobalt chrome coated titanium implant |
US9949837B2 (en) | 2013-03-07 | 2018-04-24 | Howmedica Osteonics Corp. | Partially porous bone implant keel |
US9517079B2 (en) | 2013-03-07 | 2016-12-13 | Zimmer, Inc. | Tibial resection systems and methods for cruciate ligament retainment |
ES2657682T3 (en) | 2013-03-08 | 2018-03-06 | Stryker Corporation | Bone pads |
US9757242B2 (en) | 2013-03-11 | 2017-09-12 | Howmedica Osteonics Corp. | Implant system with polymeric insert and two tray options |
US20160296289A1 (en) | 2013-03-15 | 2016-10-13 | Concepto Llc | Custom matched joint prosthesis replacement |
WO2014143740A1 (en) | 2013-03-15 | 2014-09-18 | Mako Surgical Corp. | Unicondylar tibial knee implant |
US9737408B2 (en) | 2013-03-15 | 2017-08-22 | Depuy Ireland Unlimited Company | Tibial impaction guide surgical instrument and method of using same |
US9165597B2 (en) * | 2013-06-28 | 2015-10-20 | Seagate Technology Llc | Time-multiplexed single input single output (SISO) data recovery channel |
US9757245B2 (en) | 2014-04-24 | 2017-09-12 | DePuy Synthes Products, Inc. | Patient-specific spinal fusion cage and methods of making same |
US9801727B2 (en) | 2014-05-28 | 2017-10-31 | AOD Holdings, LLC | Tibial base plate and method for attaching a tibial base plate on a tibia |
US9387085B2 (en) | 2014-05-30 | 2016-07-12 | Stryker Corporation | Stepped tibial baseplate |
US9554862B2 (en) | 2014-06-05 | 2017-01-31 | Mako Surgical Corp. | Morphologically curved sagittal wall of a tibial implant |
WO2015191956A1 (en) | 2014-06-13 | 2015-12-17 | Acuitive Technologies, Inc. | Joint replacement or joint resurfacing devices, systems and methods |
US20160015520A1 (en) | 2014-07-15 | 2016-01-21 | Biomet Manufacturing, Llc | Acetabular prosthesis liner |
US10561456B2 (en) | 2014-07-24 | 2020-02-18 | KYOCERA Medical Technologies, Inc. | Bone screw incorporating a porous surface formed by an additive manufacturing process |
AU2016200179B2 (en) | 2015-01-14 | 2020-09-17 | Stryker European Operations Holdings Llc | Spinal implant with porous and solid surfaces |
US9820858B2 (en) | 2015-03-23 | 2017-11-21 | Modal Manufacturing, LLC | Knee implants and instruments |
EP3296043A4 (en) * | 2015-05-15 | 2018-04-25 | Konica Minolta, Inc. | Powder material, method for producing three-dimensional molded article, and three-dimensional molding device |
US10548735B2 (en) | 2015-08-06 | 2020-02-04 | Howmedica Osteonics Corp. | Modular hinge knee prosthesis and improvements of same |
CA2942112A1 (en) | 2015-09-15 | 2017-03-15 | Sulzhan Bali | A composition of orthopedic knee implant and the method for manufacture thereof |
US10039645B2 (en) * | 2016-01-25 | 2018-08-07 | Depuy Ireland Unlimited Company | Releasable threaded connection for modular implants |
US10326336B2 (en) * | 2016-06-30 | 2019-06-18 | Ford Global Technologies, Llc | Coolant flow distribution using coating materials |
US10905436B2 (en) * | 2017-03-02 | 2021-02-02 | Optimotion Implants, Llc | Knee arthroplasty systems and methods |
-
2017
- 2017-06-14 US US15/622,688 patent/US10905436B2/en active Active
- 2017-06-15 US US15/624,488 patent/US10512471B2/en active Active
- 2017-06-16 US US15/625,802 patent/US10456143B2/en active Active
-
2018
- 2018-02-26 EP EP18760850.0A patent/EP3589239A1/en not_active Withdrawn
- 2018-02-26 WO PCT/US2018/019652 patent/WO2018160481A1/en active Application Filing
- 2018-02-26 WO PCT/US2018/019647 patent/WO2018160480A1/en unknown
-
2019
- 2019-10-23 US US16/660,964 patent/US20200054346A1/en not_active Abandoned
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11730603B2 (en) | 2020-09-03 | 2023-08-22 | Globus Medical, Inc. | Systems and methods for knee arthroplasty |
US11844697B2 (en) | 2020-09-03 | 2023-12-19 | Globus Medical, Inc. | Systems and methods for knee arthroplasty |
US12121449B2 (en) | 2020-09-03 | 2024-10-22 | Globus Medical, Inc. | Systems and methods for knee arthroplasty |
Also Published As
Publication number | Publication date |
---|---|
US20180250019A1 (en) | 2018-09-06 |
US10905436B2 (en) | 2021-02-02 |
US10512471B2 (en) | 2019-12-24 |
US10456143B2 (en) | 2019-10-29 |
US20180250022A1 (en) | 2018-09-06 |
WO2018160481A1 (en) | 2018-09-07 |
EP3589239A1 (en) | 2020-01-08 |
US20180250134A1 (en) | 2018-09-06 |
WO2018160480A1 (en) | 2018-09-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10456143B2 (en) | Composite joint arthroplasty systems and methods | |
US20220362026A1 (en) | Orthopedic implants and methods | |
EP2205188B1 (en) | Cementless tibial tray | |
US9707317B2 (en) | Pulsed current sintering for surfaces of medical implants | |
EP2116210B1 (en) | Knee implant | |
US9775711B2 (en) | Rapid manufacturing of porous metal prostheses | |
US7632575B2 (en) | Laser based metal deposition (LBMD) of implant structures | |
JP4248787B2 (en) | Parts for artificial joints with bearings and joint surfaces covered with diamonds | |
JP6880192B2 (en) | Implants with fragile fastener port plugs | |
Muth et al. | Novel highly porous metal technology in artificial hip and knee replacement: processing methodologies and clinical applications | |
JP2009514576A (en) | Open-hole biocompatible surface layer for implants, method for production and use thereof | |
US10285816B2 (en) | Implant including cartilage plug and porous metal | |
US20150081028A1 (en) | Adaptor for modular joint prostheses | |
CN105105883A (en) | Improved artificial knee joint femoral prosthesis with porous film and preparation method thereof | |
CN105105881A (en) | Improved artificial knee joint femoral prosthesis with porous film and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: TITANIUM FUSION TECHNOLOGIES, LLC, FLORIDA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:JUSTIN, DANIEL F.;NGUYEN, VUONG BINH;MEDLIN, DANA J.;SIGNING DATES FROM 20170525 TO 20170606;REEL/FRAME:050799/0174 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: APPLICATION DISPATCHED FROM PREEXAM, NOT YET DOCKETED |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |
|
STCB | Information on status: application discontinuation |
Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION |